Hours

0

Speakers

0

Seats

0

Investors

0

Partners

0

What is DANS Startup Showcase

Organized as a part of DANS2019, the DANS Startup Showcase aims to recognize the success and vitality of the startup companies in the DataAI sector. The DANS Startup Showcase has been established specifically to acknowledge, encourage and celebrate excellence among entrepreneurs, investors as well as executives by giving them the opportunity to gain valuable exposure and well-deserved recognition.

What is DANS Startup Showcase

2019 DANS Awards Ceremony and Reception

The 2019 DANS Awards Ceremony and Reception will be held as a part of DANS2019. The idea behind the DANS Awards is to identify and recognize the prominent companies/leaders in the field and recognize them with lectureships as well as awards. The DANS2019 showcases the leaders in the Technology, Biotech, Life Sciences, Pharma and Medtech sectors. The DANS awards are aimed to be established as one of the highest honors that can be bestowed upon DataAI stakeholders in the nation. The Awards ceremony will take place on the 6th of February 2019 at Google.

2019 DANS Awards Ceremony and Reception

Award Recipients at DANS

Award Highlights at DANS 2019

Vinod KhoslaDANS Leadership Award

It is our pleasure to announce Vinod Khosla as the winner of the inaugural DANS Leadership Award. The DANS Leadership Award honors an individual who has made outstanding contributions to the DataAI field (data analytics and artificial intelligence technologies combined). Vinod is a pioneer and a tireless advocate of the field. He is a co-founder of Sun Microsystems, the founder of Khosla Ventures, and has contributed in the creation of several successful companies in the DataAI sector. Join us in congratulating him on this wonderful recognition of his merits.

Bio: Vinod Khosla is an entrepreneur, investor and technologist. He is the founder of Khosla Ventures, a firm focused on assisting entrepreneurs to build impactful new energy and technology companies. Vinod grew up dreaming of being an entrepreneur, despite being from an Indian army household with no business or technology connections. Since the age of 16, when he first heard about the founding of Intel, he dreamt of starting his own technology company.

After graduating with a bachelor’s degree in electrical engineering from the Indian Institute of Technology (IIT) in New Delhi, Vinod failed to start a soymilk company to service the many people in India who did not have refrigerators. Instead, he came to the U.S. to further his academic studies and received a master’s degree in biomedical engineering from Carnegie Mellon University. Eventually, his startup dreams led him to Silicon Valley, where he received a master’s degree in business administration from the Stanford University Graduate School of Business.

Upon graduation, Vinod co-founded Daisy Systems, the first significant computer-aided design system for electrical engineers. The company went on to achieve significant revenue, profits and an IPO. Then, driven by the frustration of having to design the computer hardware on which the Daisy software needed to be built, Vinod started the standards-based Sun Microsystems in 1982 to build workstations for software developers. As the founding CEO of Sun, he pioneered open systems and commercial RISC processors. Sun Microsystems was funded by Vinod’s longtime friend and board member John Doerr of Kleiner Perkins Caufield and Byers (KPCB).

In 1986, Vinod joined KPCB as a general partner. While there, he played a crucial role in taking on Intel’s monopoly by building and growing semiconductor company, Nexgen, which eventually was acquired by Advanced Micro Devices (AMD). Nexgen/AMD was the only microprocessor to have significant success against Intel. Thereafter, Vinod helped incubate the idea and business plan for Juniper Networks to take on Cisco System’s dominance of the router market. He also was involved in the formulation of the early advertising-based search strategy for Excite. In addition to his many other contributions at KPCB, he helped transform the moribund telecommunications business and its archaic SONET implementations with Cerent Corporation, which was acquired by Cisco Systems in 1999 for $7.2 billion.

In 2004, driven by the need for flexibility to accommodate four teenaged children, the desire to be more experimental and to fund sometimes imprudent “science experiments,” Vinod formed Khosla Ventures to focus on both for-profit and social impact investments. His goals remain the same: work and learn from fun and knowledgeable entrepreneurs, build impactful companies by leveraging innovation and spend time with a partnership that makes a difference. Vinod has a passion for nascent technologies that have beneficial effects and economic impact on society. While he only serves on the boards of a few select companies, he works closely with most KV companies as they face transitions or key decisions.

Vinod’s greatest passion is being a mentor to entrepreneurs building technology-based businesses. He is driven by the desire to make a positive impact through scaling new energy sources, achieving petroleum independence and promoting a pragmatic approach to the environment. He also is passionate about social entrepreneurship with a special emphasis on microfinance as a poverty alleviation tool. He is a supporter of many microfinance organizations in India and Africa. He also has been experimenting with innovations in education and global housing.

Vinod also is a charter member of The Indus Entrepreneurs (TiE), a non-profit global network of entrepreneurs and professionals that was founded in 1992 and has more than 40 chapters in nine countries today. He is a founding board member of the Indian School of Business (ISB). Vinod holds a bachelor of technology degree in electrical engineering from the Indian Institute of Technology (IIT) in New Delhi, India, a master’s degree in biomedical engineering from Carnegie Mellon University and a master’s degree in business administration from the Stanford University Graduate School of Business.

Vinod KhoslaDANS Leadership Award

It is our pleasure to announce Vinod Khosla as the winner of the inaugural DANS Leadership Award. The DANS Leadership Award honors an individual who has made outstanding contributions to the DataAI field (data analytics and artificial intelligence technologies combined). Vinod is a pioneer and a tireless advocate of the field. He is a co-founder of Sun Microsystems, the founder of Khosla Ventures, and has contributed in the creation of several successful companies in the DataAI sector. Join us in congratulating him on this wonderful recognition of his merits.

Bio: Vinod Khosla is an entrepreneur, investor and technologist. He is the founder of Khosla Ventures, a firm focused on assisting entrepreneurs to build impactful new energy and technology companies. Vinod grew up dreaming of being an entrepreneur, despite being from an Indian army household with no business or technology connections. Since the age of 16, when he first heard about the founding of Intel, he dreamt of starting his own technology company.

After graduating with a bachelor’s degree in electrical engineering from the Indian Institute of Technology (IIT) in New Delhi, Vinod failed to start a soymilk company to service the many people in India who did not have refrigerators. Instead, he came to the U.S. to further his academic studies and received a master’s degree in biomedical engineering from Carnegie Mellon University. Eventually, his startup dreams led him to Silicon Valley, where he received a master’s degree in business administration from the Stanford University Graduate School of Business.

Upon graduation, Vinod co-founded Daisy Systems, the first significant computer-aided design system for electrical engineers. The company went on to achieve significant revenue, profits and an IPO. Then, driven by the frustration of having to design the computer hardware on which the Daisy software needed to be built, Vinod started the standards-based Sun Microsystems in 1982 to build workstations for software developers. As the founding CEO of Sun, he pioneered open systems and commercial RISC processors. Sun Microsystems was funded by Vinod’s longtime friend and board member John Doerr of Kleiner Perkins Caufield and Byers (KPCB).

In 1986, Vinod joined KPCB as a general partner. While there, he played a crucial role in taking on Intel’s monopoly by building and growing semiconductor company, Nexgen, which eventually was acquired by Advanced Micro Devices (AMD). Nexgen/AMD was the only microprocessor to have significant success against Intel. Thereafter, Vinod helped incubate the idea and business plan for Juniper Networks to take on Cisco System’s dominance of the router market. He also was involved in the formulation of the early advertising-based search strategy for Excite. In addition to his many other contributions at KPCB, he helped transform the moribund telecommunications business and its archaic SONET implementations with Cerent Corporation, which was acquired by Cisco Systems in 1999 for $7.2 billion.

In 2004, driven by the need for flexibility to accommodate four teenaged children, the desire to be more experimental and to fund sometimes imprudent “science experiments,” Vinod formed Khosla Ventures to focus on both for-profit and social impact investments. His goals remain the same: work and learn from fun and knowledgeable entrepreneurs, build impactful companies by leveraging innovation and spend time with a partnership that makes a difference. Vinod has a passion for nascent technologies that have beneficial effects and economic impact on society. While he only serves on the boards of a few select companies, he works closely with most KV companies as they face transitions or key decisions.

Vinod’s greatest passion is being a mentor to entrepreneurs building technology-based businesses. He is driven by the desire to make a positive impact through scaling new energy sources, achieving petroleum independence and promoting a pragmatic approach to the environment. He also is passionate about social entrepreneurship with a special emphasis on microfinance as a poverty alleviation tool. He is a supporter of many microfinance organizations in India and Africa. He also has been experimenting with innovations in education and global housing.

Vinod also is a charter member of The Indus Entrepreneurs (TiE), a non-profit global network of entrepreneurs and professionals that was founded in 1992 and has more than 40 chapters in nine countries today. He is a founding board member of the Indian School of Business (ISB). Vinod holds a bachelor of technology degree in electrical engineering from the Indian Institute of Technology (IIT) in New Delhi, India, a master’s degree in biomedical engineering from Carnegie Mellon University and a master’s degree in business administration from the Stanford University Graduate School of Business.

closepopup
Franklin UrteagaDANS Public Service Award

It is our pleasure to announce Franklin Urteaga as the winner of the inaugural DANS Public Service Award. The DANS Public Service Award is presented to an individual who has demonstrated outstanding national leadership in support of technology and/or healthcare innovation in the United States. Franklin has served the White House as a Technology Policy Advisor (from 1997 to 2000). He was also a part of the Office of Deputy Chief of Staff to President Bill Clinton and to the Office of the Vice President, Albert Gore Jr. (from 1995-1996). Among many accomplishments, Franklin was a strong advocate of internet being used in the public sector. He even launched the very first White House ‘NetDay’ to promote internet. Besides his public service, Franklin is also a successful entrepreneur and has contributed to the creation of several successful companies to revolutionize the way people use internet. Join us in congratulating him on this wonderful recognition of his merits.

Bio: Former Clinton White House Tech Advisor + Obama Campaign Aide. Expertise in Innovation + Tech Start-Ups + Artificial Intelligence + Blockchain. Helped build Global Brands (JDate, AmericanSingles, and ChristianMingle). Launched 1st "INTERNET Day" at the White House to promote Internet throughout 50 U.S. states; Helped to grow Online Dating worldwide; Launching World's 1st Fake News Filter (OIGETIT) on mobile devices worldwide. Invited as Super VIP Keynote Speaker to top Silicon Valley conferences and seminars. Also invited by the Provincial Governors and Mayors of 12 cities (Beijing, Shanghai, Chengdu, Wuhan, Guiyang, Nanjing, Jinzhou, Jinan, Hangzhou) in China to serve as Honored Keynote Speaker.

Cross-Border Innovation Expert, discussing topics such as Innovation Trends + Artificial Intelligence + Blockchain + Fintech + Cryptocurrency + Unicorn Companies + Sharing Economy Companies + Entrepreneurship + Startups + President Xi's One Belt One Road. Recently, was only American Entrepreneur Invited to be Keynote Speaker at the famous 2017 "Zhongguancun Forum" in Beijing, China. About.me/franklinurteaga

Franklin UrteagaDANS Public Service Award

It is our pleasure to announce Franklin Urteaga as the winner of the inaugural DANS Public Service Award. The DANS Public Service Award is presented to an individual who has demonstrated outstanding national leadership in support of technology and/or healthcare innovation in the United States. Franklin has served the White House as a Technology Policy Advisor (from 1997 to 2000). He was also a part of the Office of Deputy Chief of Staff to President Bill Clinton and to the Office of the Vice President, Albert Gore Jr. (from 1995-1996). Among many accomplishments, Franklin was a strong advocate of internet being used in the public sector. He even launched the very first White House ‘NetDay’ to promote internet. Besides his public service, Franklin is also a successful entrepreneur and has contributed to the creation of several successful companies to revolutionize the way people use internet. Join us in congratulating him on this wonderful recognition of his merits.

Bio: Former Clinton White House Tech Advisor + Obama Campaign Aide. Expertise in Innovation + Tech Start-Ups + Artificial Intelligence + Blockchain. Helped build Global Brands (JDate, AmericanSingles, and ChristianMingle). Launched 1st "INTERNET Day" at the White House to promote Internet throughout 50 U.S. states; Helped to grow Online Dating worldwide; Launching World's 1st Fake News Filter (OIGETIT) on mobile devices worldwide. Invited as Super VIP Keynote Speaker to top Silicon Valley conferences and seminars. Also invited by the Provincial Governors and Mayors of 12 cities (Beijing, Shanghai, Chengdu, Wuhan, Guiyang, Nanjing, Jinzhou, Jinan, Hangzhou) in China to serve as Honored Keynote Speaker.

Cross-Border Innovation Expert, discussing topics such as Innovation Trends + Artificial Intelligence + Blockchain + Fintech + Cryptocurrency + Unicorn Companies + Sharing Economy Companies + Entrepreneurship + Startups + President Xi's One Belt One Road. Recently, was only American Entrepreneur Invited to be Keynote Speaker at the famous 2017 "Zhongguancun Forum" in Beijing, China. About.me/franklinurteaga

closepopup
Gary Starling , PhD, Assoc VP, MerckClinical Development Award (for KEYTRUDA) to Merck

It is our pleasure to announce Merck, as the winner of 2019 DANS Clinical Development Award (for KEYTRUDA). 2019 DANS Clinical Development Award recognizes Merck for excellence in clinical development in regards to development of KEYTRUDA. Gary Starling, PhD, Associate Vice President, Merck, will accept the award on the behalf of Merck. Dr. Starling’s career has been focused on the Discovery and Early Development of Biologic therapeutics. He is a veteran in the BioPharmaceutical industry, and has held key positions at Bristol-Myers Squibb, CuraGen, PDL BioPharma, Facet Biotech (acquired by Abbott Labs) and Merck. Dr Sterling heads the Protein Science Department at Merck that drives the discovery of Biologics for all of Merck’s disease areas including Immuno-Oncology. Join us in congratulating Merck and Dr. Starling on this wonderful recognition.

Gary Starling , PhD, Assoc VP, MerckClinical Development Award (for KEYTRUDA) to Merck

It is our pleasure to announce Merck, as the winner of 2019 DANS Clinical Development Award (for KEYTRUDA). 2019 DANS Clinical Development Award recognizes Merck for excellence in clinical development in regards to development of KEYTRUDA. Gary Starling, PhD, Associate Vice President, Merck, will accept the award on the behalf of Merck. Dr. Starling’s career has been focused on the Discovery and Early Development of Biologic therapeutics. He is a veteran in the BioPharmaceutical industry, and has held key positions at Bristol-Myers Squibb, CuraGen, PDL BioPharma, Facet Biotech (acquired by Abbott Labs) and Merck. Dr Sterling heads the Protein Science Department at Merck that drives the discovery of Biologics for all of Merck’s disease areas including Immuno-Oncology. Join us in congratulating Merck and Dr. Starling on this wonderful recognition.

closepopup
Atul Butte, MD, PhDDANS Clinical Data Integration & Management Award to UC Health

It is our pleasure to announce University of California System (UC Health), as the winner of DANS Clinical Data Integration & Management Award. Atul Butte, MD, PhD, Chief Data Scientist of UC Health, who is heading this initiative, will accept the award on the behalf of UC Health. Dr. Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire UC Health System, with 17 health professional schools, 6 medical centers, and 10 hospitals. Dr. Butte is well published and widely recognized for his scientific work and his leadership. Dr. Butte was elected into the National Academy of Medicine in 2015, and in 2013, he was recognized by the Obama Administration as a White House Champion of Change in Open Science for promoting science through publicly available data. He has also contributed in the creation of several successful companies in the DataAI sector. Join us in congratulating UC Health and Dr. Butte on this wonderful recognition.

Atul Butte, MD, PhDDANS Clinical Data Integration & Management Award to UC Health

It is our pleasure to announce University of California System (UC Health), as the winner of DANS Clinical Data Integration & Management Award. Atul Butte, MD, PhD, Chief Data Scientist of UC Health, who is heading this initiative, will accept the award on the behalf of UC Health. Dr. Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire UC Health System, with 17 health professional schools, 6 medical centers, and 10 hospitals. Dr. Butte is well published and widely recognized for his scientific work and his leadership. Dr. Butte was elected into the National Academy of Medicine in 2015, and in 2013, he was recognized by the Obama Administration as a White House Champion of Change in Open Science for promoting science through publicly available data. He has also contributed in the creation of several successful companies in the DataAI sector. Join us in congratulating UC Health and Dr. Butte on this wonderful recognition.

closepopup

Who’s Speaking at DANS

Speaker Highlights at DANS 2019

Lynda Chin, MDProfessor, Executive Director Real-world Education, Detection and Intervention, The University of Texas System; Founder, CEO Apricity Health

An elected member of the National Academy of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation, Dr. Chin is a renowned cancer genomic scientist. At Dana-Farber Cancer Institute where she was a professor at Harvard Medical School and a senior associate member at the Broad Institute of MIT and Harvard, Dr. Chin conducted research spanning mouse models of human cancers, cancer genomics, functional genomics and personalized medicine. Outside of her laboratory, Dr. Chin held multiple leadership positions in The Cancer Genome Atlas (TCGA) project in the U.S., including serving on the executive subcommittee and leading development of Firehose pipeline as co-PI at the Broad Institute. In 2011, Dr. Chin created the first Department of Genomic Medicine at MD Anderson Cancer Center to accelerate the translation of scientific advances and democratize the best care to patients outside of academic centers with technologies, data and AI analytics. In 2015, foreseeing the need for a new model to harness the potential of real-world health and health-related data, Dr. Chin launched the Institute for Health Transformation as the Chief Innovation Officer for University of Texas System to develop REDI (Real-world Education, early Detection and Intervention), an infrastructure platform for a connected health data and care delivery ecosystem. Collaborating with public and private enterprises and engaging local stakeholders from federally qualified health center to churches, Dr. Chin established a connected ecosystem in one of the poorest communities of South Texas to demonstrate how purposeful data sharing across public and private entities is feasible and how technology can be leveraged to improve chronic disease management for a vulnerable population. Most recently, Dr. Chin founded Apricity Health to develop integrated solutions for detecting and managing treatment-related adverse events in cancer patients.

Lynda Chin, MDProfessor, Executive Director Real-world Education, Detection and Intervention, The University of Texas System; Founder, CEO Apricity Health

An elected member of the National Academy of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation, Dr. Chin is a renowned cancer genomic scientist. At Dana-Farber Cancer Institute where she was a professor at Harvard Medical School and a senior associate member at the Broad Institute of MIT and Harvard, Dr. Chin conducted research spanning mouse models of human cancers, cancer genomics, functional genomics and personalized medicine. Outside of her laboratory, Dr. Chin held multiple leadership positions in The Cancer Genome Atlas (TCGA) project in the U.S., including serving on the executive subcommittee and leading development of Firehose pipeline as co-PI at the Broad Institute. In 2011, Dr. Chin created the first Department of Genomic Medicine at MD Anderson Cancer Center to accelerate the translation of scientific advances and democratize the best care to patients outside of academic centers with technologies, data and AI analytics. In 2015, foreseeing the need for a new model to harness the potential of real-world health and health-related data, Dr. Chin launched the Institute for Health Transformation as the Chief Innovation Officer for University of Texas System to develop REDI (Real-world Education, early Detection and Intervention), an infrastructure platform for a connected health data and care delivery ecosystem. Collaborating with public and private enterprises and engaging local stakeholders from federally qualified health center to churches, Dr. Chin established a connected ecosystem in one of the poorest communities of South Texas to demonstrate how purposeful data sharing across public and private entities is feasible and how technology can be leveraged to improve chronic disease management for a vulnerable population. Most recently, Dr. Chin founded Apricity Health to develop integrated solutions for detecting and managing treatment-related adverse events in cancer patients.

closepopup
Prasun J. Mishra, MSc, PhDFounding President and CEO AAPM; Founder & CEO, Agility Pharma; Founder, MetaImmune, Inc.

Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the founder and CEO of Agility Pharmaceuticals (Agility), based in San Francisco Bay Area, CA. Agility pharma is one of the leading artificial intelligence (AI)-driven pharmaceutical companies, as evident by key partnerships, recognition by scientific and tech community. He is also the founder of MetaImmune inc., an immunotherapy company, focused on finding curative therapies for cancer through targeting tumor-immune interactions. He is also founding president and CEO of American Association for Precision Medicine (AAPM). He is best known for discovering the role for noncoding RNA in drug resistance and pharmacogenomics. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and mechanisms of action/resistance of both new and established drugs, which has facilitated development of rational drug combinations in the clinic. His research work has been recognized globally by numerous awards and honors. In addition to his professional commitments, Dr. Mishra also gives back to his local biotech community by serving as an advisor to several companies in the San Francisco Bay Area to advance their R&D and funding strategy. The companies that he has advised have raised multimillion dollars. Notably, he serves as a mentor and advisor to startup accelerators such as IndieBio, Project Zygote and California Life Sciences Association, to help grow California’s life sciences innovation ecosystem. Moreover, discoveries lead by Dr. Mishra and his teams have contributed to the development of new and viable strategies of prevention, diagnosis and treatment of patients in the clinic.

Prasun J. Mishra, MSc, PhDFounding President and CEO AAPM; Founder & CEO, Agility Pharma; Founder, MetaImmune, Inc.

Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the founder and CEO of Agility Pharmaceuticals (Agility), based in San Francisco Bay Area, CA. Agility pharma is one of the leading artificial intelligence (AI)-driven pharmaceutical companies, as evident by key partnerships, recognition by scientific and tech community. He is also the founder of MetaImmune inc., an immunotherapy company, focused on finding curative therapies for cancer through targeting tumor-immune interactions. He is also founding president and CEO of American Association for Precision Medicine (AAPM). He is best known for discovering the role for noncoding RNA in drug resistance and pharmacogenomics. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and mechanisms of action/resistance of both new and established drugs, which has facilitated development of rational drug combinations in the clinic. His research work has been recognized globally by numerous awards and honors. In addition to his professional commitments, Dr. Mishra also gives back to his local biotech community by serving as an advisor to several companies in the San Francisco Bay Area to advance their R&D and funding strategy. The companies that he has advised have raised multimillion dollars. Notably, he serves as a mentor and advisor to startup accelerators such as IndieBio, Project Zygote and California Life Sciences Association, to help grow California’s life sciences innovation ecosystem. Moreover, discoveries lead by Dr. Mishra and his teams have contributed to the development of new and viable strategies of prevention, diagnosis and treatment of patients in the clinic.

closepopup
John Mattison, MDChief Medical Information Officer, Kaiser Permanente

John Mattison, is the Chief Medical Information Officer and Assistant Medical Director for Kaiser Permanente. He focuses on transforming care delivery with information technology, through convergence of exponential technologies and data liquidity. He led the design and implementation of the largest integrated electronic health record in the US, and leads various national programs including virtual care. He has sponsored or led numerous digital innovations, and mentors many digital health startups. He chairs the eHealth Workgroup of the Global Alliance for Genomics and Health (GA4GH), and is a board member of Open mHealth, advisory board member of the NIH funded Policy and Ethics in Precision Medicine, teaches at multiple Universities including Singularity University, and has published widely on privacy, policy, security, IOT, global genomics collaboration, interoperability, mobile health, and healthcare transformation. He has published in Nature, JAMIA, JAMA, WSJ, Forbes, and has authored chapters for various books. He has keynoted or hosted many national and international healthcare conferences and has consulted in many countries. He is the founder of the international XML standard for health record interoperability known as CDA, CCD and CCDA, and is an active participant on several global initiatives to bring internet services to underserved communities providing access to both jobs and healthcare.

John Mattison, MDChief Medical Information Officer, Kaiser Permanente

John Mattison, is the Chief Medical Information Officer and Assistant Medical Director for Kaiser Permanente. He focuses on transforming care delivery with information technology, through convergence of exponential technologies and data liquidity. He led the design and implementation of the largest integrated electronic health record in the US, and leads various national programs including virtual care. He has sponsored or led numerous digital innovations, and mentors many digital health startups. He chairs the eHealth Workgroup of the Global Alliance for Genomics and Health (GA4GH), and is a board member of Open mHealth, advisory board member of the NIH funded Policy and Ethics in Precision Medicine, teaches at multiple Universities including Singularity University, and has published widely on privacy, policy, security, IOT, global genomics collaboration, interoperability, mobile health, and healthcare transformation. He has published in Nature, JAMIA, JAMA, WSJ, Forbes, and has authored chapters for various books. He has keynoted or hosted many national and international healthcare conferences and has consulted in many countries. He is the founder of the international XML standard for health record interoperability known as CDA, CCD and CCDA, and is an active participant on several global initiatives to bring internet services to underserved communities providing access to both jobs and healthcare.

closepopup
Franklin UrteagaFormer White House Innovation Advisor, Co-founder, OIGETIT Fake News Filter

Former Clinton White House Tech Advisor + Obama Campaign Aide. Expertise in Innovation + Tech Start-Ups + Artificial Intelligence + Blockchain. Helped build Global Brands (JDate, AmericanSingles, and ChristianMingle). Launched 1st "INTERNET Day" at the White House to promote Internet throughout 50 U.S. states; Helped to grow Online Dating worldwide; Launching World's 1st Fake News Filter (OIGETIT) on mobile devices worldwide. Invited as Super VIP Keynote Speaker to top Silicon Valley conferences and seminars. Also invited by the Provincial Governors and Mayors of 12 cities (Beijing, Shanghai, Chengdu, Wuhan, Guiyang, Nanjing, Jinzhou, Jinan, Hangzhou) in China to serve as Honored Keynote Speaker.

Cross-Border Innovation Expert, discussing topics such as Innovation Trends + Artificial Intelligence + Blockchain + Fintech + Cryptocurrency + Unicorn Companies + Sharing Economy Companies + Entrepreneurship + Startups + President Xi's One Belt One Road. Recently, was only American Entrepreneur Invited to be Keynote Speaker at the famous 2017 "Zhongguancun Forum" in Beijing, China. About.me/franklinurteaga

Franklin UrteagaFormer White House Innovation Advisor, Co-founder, OIGETIT Fake News Filter

Former Clinton White House Tech Advisor + Obama Campaign Aide. Expertise in Innovation + Tech Start-Ups + Artificial Intelligence + Blockchain. Helped build Global Brands (JDate, AmericanSingles, and ChristianMingle). Launched 1st "INTERNET Day" at the White House to promote Internet throughout 50 U.S. states; Helped to grow Online Dating worldwide; Launching World's 1st Fake News Filter (OIGETIT) on mobile devices worldwide. Invited as Super VIP Keynote Speaker to top Silicon Valley conferences and seminars. Also invited by the Provincial Governors and Mayors of 12 cities (Beijing, Shanghai, Chengdu, Wuhan, Guiyang, Nanjing, Jinzhou, Jinan, Hangzhou) in China to serve as Honored Keynote Speaker.

Cross-Border Innovation Expert, discussing topics such as Innovation Trends + Artificial Intelligence + Blockchain + Fintech + Cryptocurrency + Unicorn Companies + Sharing Economy Companies + Entrepreneurship + Startups + President Xi's One Belt One Road. Recently, was only American Entrepreneur Invited to be Keynote Speaker at the famous 2017 "Zhongguancun Forum" in Beijing, China. About.me/franklinurteaga

closepopup
Ming Jack Po, MD, PhDProduct Manager at Google Brain and Google Cloud

Jack Po is a product manager at Google working on medical brain and health cloud. Previously, he has also spent time in Google’s search unit working on health related queries. Prior to Google, Jack spent a decade working in venture capital and medical devices. Jack also has a strong interest in health care policy and global health, and he has served in various advisory capacities to NGOs / ministries of health on the scale up of healthcare and education systems.

Ming Jack Po, MD, PhDProduct Manager at Google Brain and Google Cloud

Jack Po is a product manager at Google working on medical brain and health cloud. Previously, he has also spent time in Google’s search unit working on health related queries. Prior to Google, Jack spent a decade working in venture capital and medical devices. Jack also has a strong interest in health care policy and global health, and he has served in various advisory capacities to NGOs / ministries of health on the scale up of healthcare and education systems.

closepopup
David Shaywitz, MD, PhDSenior Partner at Takeda Ventures, Inc.

David's career focus has been translating promising science into clinical impact. He trained as physician-scientist at Harvard and MIT, did his medicine and endocrinology training at MGH, and his post-doc in the Melton Lab at the Harvard Stem Cell Institute. He spent the following decade in and around pharma including several years in experimental medicine at Merck, several years at BCG, and several years at Theravance in South San Francisco. From 2014-2017, he was the Chief Medical Officer of the cloud genomics company, DNAnexus. David is passionate about the opportunities at the intersection of technology and health; at Takeda Ventures, which he joined as a Senior Partner in 2017, he is building out a data science and technology (DST) capability. David also writes about issues related to entrepreneurship, technology, innovation, and medicine, including occasional commentaries for WSJ, FT, WaPo, etc, and writes a regular blog at Forbes. Since 2015 he has co-hosted a twice-monthly podcast on tech & health, "Tech Tonics," with Lisa Suennen.

David Shaywitz, MD, PhDSenior Partner at Takeda Ventures, Inc.

David's career focus has been translating promising science into clinical impact. He trained as physician-scientist at Harvard and MIT, did his medicine and endocrinology training at MGH, and his post-doc in the Melton Lab at the Harvard Stem Cell Institute. He spent the following decade in and around pharma including several years in experimental medicine at Merck, several years at BCG, and several years at Theravance in South San Francisco. From 2014-2017, he was the Chief Medical Officer of the cloud genomics company, DNAnexus. David is passionate about the opportunities at the intersection of technology and health; at Takeda Ventures, which he joined as a Senior Partner in 2017, he is building out a data science and technology (DST) capability. David also writes about issues related to entrepreneurship, technology, innovation, and medicine, including occasional commentaries for WSJ, FT, WaPo, etc, and writes a regular blog at Forbes. Since 2015 he has co-hosted a twice-monthly podcast on tech & health, "Tech Tonics," with Lisa Suennen.

closepopup
Rashmi GopinathPartner at M12 (fka Microsoft Ventures)

Rashmi leads enterprise software investments for M12 in the Bay Area. She brings a combination of strong venture capital and startup operating experience. Previously, Rashmi was an Investment Director at Intel Capital focused on investing in cloud, infrastructure, and big data companies. She also led global business development for high-growth startups Couchbase and BlueData. Prior to that, she held business development and product development positions at GE and Oracle. Rashmi has an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a Bachelor of Engineering from the University of Mumbai in India.

Rashmi GopinathPartner at M12 (fka Microsoft Ventures)

Rashmi leads enterprise software investments for M12 in the Bay Area. She brings a combination of strong venture capital and startup operating experience. Previously, Rashmi was an Investment Director at Intel Capital focused on investing in cloud, infrastructure, and big data companies. She also led global business development for high-growth startups Couchbase and BlueData. Prior to that, she held business development and product development positions at GE and Oracle. Rashmi has an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a Bachelor of Engineering from the University of Mumbai in India.

closepopup
Rave Harpaz, PhDSenior Director, Research & Data Science at Oracle Health Sciences

Rave Harpaz is a Senior Director Research & Data Science at Oracle Health Sciences at Oracle Health Sciences. Previously, Rave was a Research Scientist at the Center for Biomedical Informatics Research, Stanford University (2012- 2014), a post-doctoral fellow at the Department of Biomedical Informatics Columbia University (2009-2012), and a quantitative risk modeling analyst at Merrill Lynch (2007-2009). Rave holds a PhD in Computer Science from the City University of New York (2008) specializing in the area of unsupervised Machine Learning, and holds a Law degree (LLB) from Tel-Aviv University, Israel.
Rave’s current research is focused on methods to extract and combine drug safety information from several data sources including: health records, spontaneous reports, the biomedical literature, biological databases, and the social media

Rave Harpaz, PhDSenior Director, Research & Data Science at Oracle Health Sciences

Rave Harpaz is a Senior Director Research & Data Science at Oracle Health Sciences at Oracle Health Sciences. Previously, Rave was a Research Scientist at the Center for Biomedical Informatics Research, Stanford University (2012- 2014), a post-doctoral fellow at the Department of Biomedical Informatics Columbia University (2009-2012), and a quantitative risk modeling analyst at Merrill Lynch (2007-2009). Rave holds a PhD in Computer Science from the City University of New York (2008) specializing in the area of unsupervised Machine Learning, and holds a Law degree (LLB) from Tel-Aviv University, Israel.
Rave’s current research is focused on methods to extract and combine drug safety information from several data sources including: health records, spontaneous reports, the biomedical literature, biological databases, and the social media

closepopup
George Dai, PhDSr. Principal Research Scientist, Johnson & Johnson

George Dai is a veteran scientist during his 20+ years of career, working for Abbott Laboratories and
Johnson & Johnson among others, chronically, in the areas of natural language search, CRM and data
mining, vision treatment algorithm design, vision optimization, and AI for medical devices. Areas of
interest include optical science, image processing, vision, visual and ophthalmic optics, optical
aberrations, astronomy, statistics, data modeling and numerical simulations, deep leaning, search
technology, big data and business analytics. George has a bachelor’s in physics and PhD in astronomy.
He published more than 30 peer-reviewed articles, one book and three book chapters, as well as 80
issued US patents. He is a fellow of the American Academy of Optometry and an associate fellow of
Abbott’s Volwiler Society. In his spare time, George is a seasoned investor in the areas of traditional and
alternative investments and owns an investment advisory business. He is also a certified yoga teacher
and enjoy swimming and volunteered leading Science Olympiad activities.

George Dai, PhDSr. Principal Research Scientist, Johnson & Johnson

George Dai is a veteran scientist during his 20+ years of career, working for Abbott Laboratories and
Johnson & Johnson among others, chronically, in the areas of natural language search, CRM and data
mining, vision treatment algorithm design, vision optimization, and AI for medical devices. Areas of
interest include optical science, image processing, vision, visual and ophthalmic optics, optical
aberrations, astronomy, statistics, data modeling and numerical simulations, deep leaning, search
technology, big data and business analytics. George has a bachelor’s in physics and PhD in astronomy.
He published more than 30 peer-reviewed articles, one book and three book chapters, as well as 80
issued US patents. He is a fellow of the American Academy of Optometry and an associate fellow of
Abbott’s Volwiler Society. In his spare time, George is a seasoned investor in the areas of traditional and
alternative investments and owns an investment advisory business. He is also a certified yoga teacher
and enjoy swimming and volunteered leading Science Olympiad activities.

closepopup
Robert Zhang, PhDCo-Founder, President, CloudMinds Technology

Dr. Robert Zhang, is Co-Founder and President of CloudMinds Technology, where he is responsible for the company’s global business and product strategies, operations, and strategic partnerships.
Before co-founding CloudMinds, Robert has been working for Samsung, Irdeto, Joint Innovation Lab, Microsoft, and Apple from 2001 to 2015. He was the Head of Service Strategy and Operations for Samsung Telecommunications America. Previously, he was VP of Product Management at Irdeto. From 2009-11, he served as VP of Product Development at the Joint Innovation Lab. Prior to these senior executive roles, he was a Senior Program Manager at Microsoft and as IPod Operations Program Manager and as Senior Engineering Scientist at Apple.
Robert earned a Ph.D. and M.S. in Computational Mechanics and M.S. in Electrical Engineering and Computer Science from the University of Illinois, an M.S. in Management Science and Engineering from Stanford University, and a B.S. from Tongji University, China.

Robert Zhang, PhDCo-Founder, President, CloudMinds Technology

Dr. Robert Zhang, is Co-Founder and President of CloudMinds Technology, where he is responsible for the company’s global business and product strategies, operations, and strategic partnerships.
Before co-founding CloudMinds, Robert has been working for Samsung, Irdeto, Joint Innovation Lab, Microsoft, and Apple from 2001 to 2015. He was the Head of Service Strategy and Operations for Samsung Telecommunications America. Previously, he was VP of Product Management at Irdeto. From 2009-11, he served as VP of Product Development at the Joint Innovation Lab. Prior to these senior executive roles, he was a Senior Program Manager at Microsoft and as IPod Operations Program Manager and as Senior Engineering Scientist at Apple.
Robert earned a Ph.D. and M.S. in Computational Mechanics and M.S. in Electrical Engineering and Computer Science from the University of Illinois, an M.S. in Management Science and Engineering from Stanford University, and a B.S. from Tongji University, China.

closepopup
Anupam Agarwal, MD, MPHVP, Harvard Club SF; VP, Zogenix Inc.

Anupam Agarwal is the Vice President and global head of safety & pharmacovigilance at Zogenix Inc. He is a cardiologist by training with over two decades of experience in treating patients and clinical research in academia. He is working in the pharmaceutical industry for more than 12 years. He was involved with research in the genetics of hypertension; drug eluted coronary stents at Brigham and Women’s Hospital, Harvard Medical School.

Anupam holds a medical degree from the GSVM Medical College, Kanpur, India and a Master of Public Health degree from the Harvard School of Public Health. He is a member of scientific oversight committee at the Cardiac Safety Research Consortium (CSRC) a think tank which was launched through an FDA Critical Path Initiative with Duke University to support research into the evaluation of cardiac safety of medical products.

Anupam Agarwal, MD, MPHVP, Harvard Club SF; VP, Zogenix Inc.

Anupam Agarwal is the Vice President and global head of safety & pharmacovigilance at Zogenix Inc. He is a cardiologist by training with over two decades of experience in treating patients and clinical research in academia. He is working in the pharmaceutical industry for more than 12 years. He was involved with research in the genetics of hypertension; drug eluted coronary stents at Brigham and Women’s Hospital, Harvard Medical School.

Anupam holds a medical degree from the GSVM Medical College, Kanpur, India and a Master of Public Health degree from the Harvard School of Public Health. He is a member of scientific oversight committee at the Cardiac Safety Research Consortium (CSRC) a think tank which was launched through an FDA Critical Path Initiative with Duke University to support research into the evaluation of cardiac safety of medical products.

closepopup
Uli K. Chettipally, MD.Co-founder & CTO, CREST Network, Kaiser Permanente

Dr. Chettipally is a speaker, emergency physician, researcher, and an innovator. He is passionate about the technology-enabled care that can decrease the burden on physicians and increase the value for patients. As the Co-founder and Chief Technology Officer of CREST Network, he designed, developed and implemented a clinical decision support platform to deliver real-time guidance at the point of care, to decrease the cognitive burden on physicians and improve patient outcomes in 21 hospitals. He received the "Pioneer Award" from Kaiser Permanente Innovations and "Morris F. Collen Research Award" from The Permanente Medical Group for his groundbreaking work. His other roles include President, Society of Physician Entrepreneurs, San Francisco Bay Area chapter; Assistant Clinical Professor of Medicine at the University of California, San Francisco; and is the Secretary/Treasurer, San Mateo County Medical Association.

Uli K. Chettipally, MD.Co-founder & CTO, CREST Network, Kaiser Permanente

Dr. Chettipally is a speaker, emergency physician, researcher, and an innovator. He is passionate about the technology-enabled care that can decrease the burden on physicians and increase the value for patients. As the Co-founder and Chief Technology Officer of CREST Network, he designed, developed and implemented a clinical decision support platform to deliver real-time guidance at the point of care, to decrease the cognitive burden on physicians and improve patient outcomes in 21 hospitals. He received the "Pioneer Award" from Kaiser Permanente Innovations and "Morris F. Collen Research Award" from The Permanente Medical Group for his groundbreaking work. His other roles include President, Society of Physician Entrepreneurs, San Francisco Bay Area chapter; Assistant Clinical Professor of Medicine at the University of California, San Francisco; and is the Secretary/Treasurer, San Mateo County Medical Association.

closepopup
Alan S. Young, MD, MBA, PMPChief Medical Officer, GYANT

Dr. Alan Young is a physician leader with strong clinical and business accomplishments. After completing a dual MD/MBA degree program at USC's Keck School of Medicine & Marshall School of Business, he obtained his medical license during his Orthopedic Surgery residency. Combining his passion for business & medicine, he served as a national healthcare subject matter expert Specialist Senior Consultant with Deloitte Consulting while providing surgical physician services at Southern California Kaiser Permanente. At USC Care Medical Group he was the Director of Operations Strategy and Special Projects, leading ambulatory quality improvement initiatives and electronic health record optimization efforts to improve both patient and physician engagement. He served as the Regional Director of Client Relations with Sagacious Consultants and Senior Manager with Accenture to drive business development for EPIC EMR solutions and recently was the Client Service Leader for Slalom Consulting in LA building their healthcare and life sciences portfolio while working with large health systems and insurance companies. Currently, he is the Chief Medical Officer for Gyant, an artificial intelligence powered software company working to engage patients and providers. He is a regular speaker and moderator for HIMSS, Health Care Executives and AI Med as well as a contributing author to a text book on Digital Health Entrepreneurship.

His clinical experience spans across Orthopedic/General Surgery, Emergency Medicine, Urgent Care, outpatient ambulatory clinics, specialty pediatric hospitals, HMO and VA hospitals. International health experience includes completion of a clinical elective program at the National Taiwan University School of Medicine in Orthopedics as well as two volunteer medical missions trips to Cambodia and Haiti. He currently practices medicine in the greater Los Angeles area and he also serves as the So Cal HIMSS CMIO Committee Chair, Society of Physician Entrepreneurs LA Chapter Leader, AIMed Ambassador and a ScaleLA Healthcare Committee member.

Alan S. Young, MD, MBA, PMPChief Medical Officer, GYANT

Dr. Alan Young is a physician leader with strong clinical and business accomplishments. After completing a dual MD/MBA degree program at USC's Keck School of Medicine & Marshall School of Business, he obtained his medical license during his Orthopedic Surgery residency. Combining his passion for business & medicine, he served as a national healthcare subject matter expert Specialist Senior Consultant with Deloitte Consulting while providing surgical physician services at Southern California Kaiser Permanente. At USC Care Medical Group he was the Director of Operations Strategy and Special Projects, leading ambulatory quality improvement initiatives and electronic health record optimization efforts to improve both patient and physician engagement. He served as the Regional Director of Client Relations with Sagacious Consultants and Senior Manager with Accenture to drive business development for EPIC EMR solutions and recently was the Client Service Leader for Slalom Consulting in LA building their healthcare and life sciences portfolio while working with large health systems and insurance companies. Currently, he is the Chief Medical Officer for Gyant, an artificial intelligence powered software company working to engage patients and providers. He is a regular speaker and moderator for HIMSS, Health Care Executives and AI Med as well as a contributing author to a text book on Digital Health Entrepreneurship.

His clinical experience spans across Orthopedic/General Surgery, Emergency Medicine, Urgent Care, outpatient ambulatory clinics, specialty pediatric hospitals, HMO and VA hospitals. International health experience includes completion of a clinical elective program at the National Taiwan University School of Medicine in Orthopedics as well as two volunteer medical missions trips to Cambodia and Haiti. He currently practices medicine in the greater Los Angeles area and he also serves as the So Cal HIMSS CMIO Committee Chair, Society of Physician Entrepreneurs LA Chapter Leader, AIMed Ambassador and a ScaleLA Healthcare Committee member.

closepopup
Suzanne BelinsonVP, Tempus, Inc.

Suzanne Belinson, PhD, MPH, is Vice President of Commercial Markets at Tempus Labs Inc. Tempus is a technology company building the world’s largest library of clinical and molecular data and an operating system to make that data accessible and useful, starting with cancer. Her role focuses on commercial growth for Tempus through the development and execution of partnerships with organizations aiming to improve healthcare value and outcomes by leveraging molecular and clinical data.

Before joining Tempus, Dr. Belinson served as a Executive Director, Clinical Markets, at the Blue Cross Blue Shield Association. In addition to leading the sales and market development for products and services developed within the Office of Clinical Affairs, Dr. Belinson led the day to day operations of Evidence Street. As part of the leadership team in the Office of Clinical Affairs she also spent time focused on the development of emerging programs and services that enhance value and brand leadership for the independent BCBS Plans.

Dr. Belinson received her bachelor’s degree from Cleveland State University, and a PhD in Epidemiology from the University of North Carolina at Chapel Hill. She also holds a Masters in Public Health from the University of Pittsburgh.

Suzanne BelinsonVP, Tempus, Inc.

Suzanne Belinson, PhD, MPH, is Vice President of Commercial Markets at Tempus Labs Inc. Tempus is a technology company building the world’s largest library of clinical and molecular data and an operating system to make that data accessible and useful, starting with cancer. Her role focuses on commercial growth for Tempus through the development and execution of partnerships with organizations aiming to improve healthcare value and outcomes by leveraging molecular and clinical data.

Before joining Tempus, Dr. Belinson served as a Executive Director, Clinical Markets, at the Blue Cross Blue Shield Association. In addition to leading the sales and market development for products and services developed within the Office of Clinical Affairs, Dr. Belinson led the day to day operations of Evidence Street. As part of the leadership team in the Office of Clinical Affairs she also spent time focused on the development of emerging programs and services that enhance value and brand leadership for the independent BCBS Plans.

Dr. Belinson received her bachelor’s degree from Cleveland State University, and a PhD in Epidemiology from the University of North Carolina at Chapel Hill. She also holds a Masters in Public Health from the University of Pittsburgh.

closepopup
Arundhati ParmarVP & Editor-In-Chief for MedCity News

Arundhati Parmar is VP & Editor-In-Chief for MedCity News, where she is responsible for the overall editorial mission for MedCityNews.com and the content strategy for MedCity’s conferences.

This is Arundhati’s second stint at MedCity. Before rejoining as editor, Arundhati was senior editor at UBM’s Medical Device + Diagnostic Industry where she also developed conference content for UBM’s live events in addition to reporting on the device industry.

In her career, Arundhati has reported on everything from manufacturing, labor unions, insurance, economic development, Silicon Valley and high-tech but fell in love with healthcare reporting and writing. She has won journalism awards from the Minnesota Chapter of the Society of Professional Journalists and Western Publishing Association

Arundhati has three degrees from three continents – a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago.

She has sworn never to enter a classroom again.

Arundhati ParmarVP & Editor-In-Chief for MedCity News

Arundhati Parmar is VP & Editor-In-Chief for MedCity News, where she is responsible for the overall editorial mission for MedCityNews.com and the content strategy for MedCity’s conferences.

This is Arundhati’s second stint at MedCity. Before rejoining as editor, Arundhati was senior editor at UBM’s Medical Device + Diagnostic Industry where she also developed conference content for UBM’s live events in addition to reporting on the device industry.

In her career, Arundhati has reported on everything from manufacturing, labor unions, insurance, economic development, Silicon Valley and high-tech but fell in love with healthcare reporting and writing. She has won journalism awards from the Minnesota Chapter of the Society of Professional Journalists and Western Publishing Association

Arundhati has three degrees from three continents – a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago.

She has sworn never to enter a classroom again.

closepopup
Roger RoyseFounder at Royse Law Firm

Roger Royse, the founder of the Royse Law Firm, works with companies ranging from newly formed tech startups to publicly traded multinationals in a variety of industries. Roger regularly advises on complex tax structuring, high stakes business negotiations and large international financial transactions. Practicing business and tax law since 1984, Roger’s background includes work with prominent San Francisco Bay area law firms, as well as Milbank, Tweed, Hadley and McCloy in New York City.

Roger is active in leadership roles with several bar associations, including the following:

• Chair of the Taxation Committee of the ABA Business Law Section;
• Vice Chair of the Tax Policy and Simplification Committee of the ABA Tax Section;
• Chair of the Tax Policy, Practice and Legislation of the State Bar of California Taxation Section;
• Fellow of the American Bar Foundation;
• California State Delegate to the ABA House of Delegates; and
• Member of the California Bar Business Law Section Agri-Business Committee.

Roger is the author of Dead on Arrival: How to Avoid the Legal Mistakes That Could Kill Your Startup and sits on the boards of advisers and mentors several funds, accelerators and tech companies and takes an active role in the strategic planning decisions of his clients.

Roger has been a participating instructor of corporate law for the Center for International Studies (Salzburg Austria) and is an adjunct Professor of Taxation (Property Transactions and International Taxation) for Golden Gate University School of Law. Roger is the founder of the philanthropic organization “Team Motion to Dismiss Cancer” which conducted high profile auctions of meetings with venture capitalists to raise money for charity and has been recognized for his efforts on behalf of The Leukemia & Lymphoma Society by being named the 2012 San Francisco Bay Area Chapter Man of the Year.

Roger RoyseFounder at Royse Law Firm

Roger Royse, the founder of the Royse Law Firm, works with companies ranging from newly formed tech startups to publicly traded multinationals in a variety of industries. Roger regularly advises on complex tax structuring, high stakes business negotiations and large international financial transactions. Practicing business and tax law since 1984, Roger’s background includes work with prominent San Francisco Bay area law firms, as well as Milbank, Tweed, Hadley and McCloy in New York City.

Roger is active in leadership roles with several bar associations, including the following:

• Chair of the Taxation Committee of the ABA Business Law Section;
• Vice Chair of the Tax Policy and Simplification Committee of the ABA Tax Section;
• Chair of the Tax Policy, Practice and Legislation of the State Bar of California Taxation Section;
• Fellow of the American Bar Foundation;
• California State Delegate to the ABA House of Delegates; and
• Member of the California Bar Business Law Section Agri-Business Committee.

Roger is the author of Dead on Arrival: How to Avoid the Legal Mistakes That Could Kill Your Startup and sits on the boards of advisers and mentors several funds, accelerators and tech companies and takes an active role in the strategic planning decisions of his clients.

Roger has been a participating instructor of corporate law for the Center for International Studies (Salzburg Austria) and is an adjunct Professor of Taxation (Property Transactions and International Taxation) for Golden Gate University School of Law. Roger is the founder of the philanthropic organization “Team Motion to Dismiss Cancer” which conducted high profile auctions of meetings with venture capitalists to raise money for charity and has been recognized for his efforts on behalf of The Leukemia & Lymphoma Society by being named the 2012 San Francisco Bay Area Chapter Man of the Year.

closepopup
Andre WatsonFounder, CEO, Ligandal

Andre founded Ligandal to enable programming of biological matter with nanomaterials, ultimately with the aim of extending human lives and creating curative genomic therapies. While studying Biomedical Engineering and Biomaterials at RPI, he created a proof of concept for Ligandal's nanoparticle-based gene delivery platform, and the world’s first non-viral system for delivering guided nucleases in vivo. Andre created the proof of concept for the first technology capable of cell-specifically targeting gene editing constructs. Andre splits his attention between financing, business development, IP and designing biomimetic nanoparticle architectures. His vision for Ligandal is to enable a new era in personalized medicine and globally accessible gene therapy.

Andre WatsonFounder, CEO, Ligandal

Andre founded Ligandal to enable programming of biological matter with nanomaterials, ultimately with the aim of extending human lives and creating curative genomic therapies. While studying Biomedical Engineering and Biomaterials at RPI, he created a proof of concept for Ligandal's nanoparticle-based gene delivery platform, and the world’s first non-viral system for delivering guided nucleases in vivo. Andre created the proof of concept for the first technology capable of cell-specifically targeting gene editing constructs. Andre splits his attention between financing, business development, IP and designing biomimetic nanoparticle architectures. His vision for Ligandal is to enable a new era in personalized medicine and globally accessible gene therapy.

closepopup
Brady DavisVP, Strategy & Marketing, DNAnexus

Brady brings over 15 years experience as an innovator and leader in the life sciences space as well as the hospital ACO and consumer health and wellness industries. Prior to DNAnexus, Brady was head of strategy and market development for Illumina with a special focus on Informatics and driving opportunities to use genetics data as clinical utility. Brady serves on the board of multiple non-profit organizations including the Global Alzheimer’s Association Interactive Network (GAAIN), Cancer Commons, Ci4CC, and is Co-Chair of the Advisory Board for the University of Washington Center for Commercialization (C4C). Brady is a graduate of University of Washington.

Brady DavisVP, Strategy & Marketing, DNAnexus

Brady brings over 15 years experience as an innovator and leader in the life sciences space as well as the hospital ACO and consumer health and wellness industries. Prior to DNAnexus, Brady was head of strategy and market development for Illumina with a special focus on Informatics and driving opportunities to use genetics data as clinical utility. Brady serves on the board of multiple non-profit organizations including the Global Alzheimer’s Association Interactive Network (GAAIN), Cancer Commons, Ci4CC, and is Co-Chair of the Advisory Board for the University of Washington Center for Commercialization (C4C). Brady is a graduate of University of Washington.

closepopup
Kamala Maddali, DVM, PhDVP, Cancer Genetics, Inc.

Kamala K. Maddali, DVM, Ph.D, is Vice President, Biopharma Collaborations and Companion Diagnostics at Cancer Genetics Inc. She joined CGI in 2015, and plays a pivotal role in the biomarker and companion diagnostics strategy in the context of pharma novel drug development programs.

Dr. Maddali brings over 10 years of extensive experience of global P&L scientific and commercial management of clinical biomarker and companion diagnostics (CDx) services covering personalized medicine strategy. She has promoted the proper utilization of biomarkers, personalized medicine and diagnostics in drug development and patient management to bridge the gap between drug and diagnostic industries. She was Global Director Scientific Development -Biomarkers & Companion Diagnostics for Q2 Solutions (A Quintiles & Quest Diagnostics joint venture). She brings a lot of strategic values from her previous roles at Quest Diagnostics, Quintiles and Merck Schering Plough in the arena of biomarkers and companion diagnostics.

Dr. Maddali holds a DVM Ph.D., in Pharmacology from University of Missouri-Columbia and a DVM Veterinary Medicine from Acharya N.G. Ranga Agricultural University in India.

Kamala Maddali, DVM, PhDVP, Cancer Genetics, Inc.

Kamala K. Maddali, DVM, Ph.D, is Vice President, Biopharma Collaborations and Companion Diagnostics at Cancer Genetics Inc. She joined CGI in 2015, and plays a pivotal role in the biomarker and companion diagnostics strategy in the context of pharma novel drug development programs.

Dr. Maddali brings over 10 years of extensive experience of global P&L scientific and commercial management of clinical biomarker and companion diagnostics (CDx) services covering personalized medicine strategy. She has promoted the proper utilization of biomarkers, personalized medicine and diagnostics in drug development and patient management to bridge the gap between drug and diagnostic industries. She was Global Director Scientific Development -Biomarkers & Companion Diagnostics for Q2 Solutions (A Quintiles & Quest Diagnostics joint venture). She brings a lot of strategic values from her previous roles at Quest Diagnostics, Quintiles and Merck Schering Plough in the arena of biomarkers and companion diagnostics.

Dr. Maddali holds a DVM Ph.D., in Pharmacology from University of Missouri-Columbia and a DVM Veterinary Medicine from Acharya N.G. Ranga Agricultural University in India.

closepopup
Ed Addison, MBAChairman, CEO, Cloud Pharmaceuticals,

Ed Addison, is Chairman and CEO of Cloud Pharmaceuticals, an established leader in Artificial Intelligence based drug design and development located in Research Triangle Park. Cloud Pharmaceuticals has new drugs in development for cancer, inflammation and rare diseases. Ed is also Chairman of 57-on-Fire, a clinical stage rare disease pharmaceutical company, and he serves on several other boards. His expertise is in deploying exponential technologies in health care, life sciences, artificial intelligence enabled ventures, and information technology.

With a technical background in Artificial Intelligence and a strong business development and capital raising background, Ed is an established serial entrepreneur of disruptive ventures. Ed started 7 companies, funded 5 of them and exited 3. He has twice been named "Entrepreneur of the Year". He has advised 7 venture capital funds and over 20 early stage ventures.

Ed is an adjunct professor of business and entrepreneurship for MBA and engineering students. He has previously taught Artificial Intelligence, Computer Science, and Bioinformatics for several universities including NC State University, Stevens Institute of Technology and Johns Hopkins University. Ed holds a BSEE from Virginia Tech, two MS degrees from Johns Hopkins, an MBA from Duke University, and an 'online' law degree from Concord Law School at Perdue University. He completed a sabbatical year at MIT in Artificial Intelligence.

Ed Addison, MBAChairman, CEO, Cloud Pharmaceuticals,

Ed Addison, is Chairman and CEO of Cloud Pharmaceuticals, an established leader in Artificial Intelligence based drug design and development located in Research Triangle Park. Cloud Pharmaceuticals has new drugs in development for cancer, inflammation and rare diseases. Ed is also Chairman of 57-on-Fire, a clinical stage rare disease pharmaceutical company, and he serves on several other boards. His expertise is in deploying exponential technologies in health care, life sciences, artificial intelligence enabled ventures, and information technology.

With a technical background in Artificial Intelligence and a strong business development and capital raising background, Ed is an established serial entrepreneur of disruptive ventures. Ed started 7 companies, funded 5 of them and exited 3. He has twice been named "Entrepreneur of the Year". He has advised 7 venture capital funds and over 20 early stage ventures.

Ed is an adjunct professor of business and entrepreneurship for MBA and engineering students. He has previously taught Artificial Intelligence, Computer Science, and Bioinformatics for several universities including NC State University, Stevens Institute of Technology and Johns Hopkins University. Ed holds a BSEE from Virginia Tech, two MS degrees from Johns Hopkins, an MBA from Duke University, and an 'online' law degree from Concord Law School at Perdue University. He completed a sabbatical year at MIT in Artificial Intelligence.

closepopup
Pinaki Dasgupta, MBAFounder, CEO, Hindsait, Inc.

Pinaki Dasgupta is a visionary entrepreneur and passionate advocate of Artificial Intelligence (AI) technology to transform healthcare. A former Accenture Partner, Pinaki had founded Hindsait in 2013 to prevent unnecessary health services, errors and frauds.
Under Dasgupta's leadership, Hindsait’s AI technology has been adopted by leading Fortune 500 healthcare organizations across USA. Hindsait has received multiple accolades and recognitions including prestigious Gartner’s “Cool vendor in AI in Healthcare 2017” and “Top 10 Artificial Intelligence Solution Provider 2018” by Healthcare Tech Outlook, among others.

Pinaki Dasgupta, MBAFounder, CEO, Hindsait, Inc.

Pinaki Dasgupta is a visionary entrepreneur and passionate advocate of Artificial Intelligence (AI) technology to transform healthcare. A former Accenture Partner, Pinaki had founded Hindsait in 2013 to prevent unnecessary health services, errors and frauds.
Under Dasgupta's leadership, Hindsait’s AI technology has been adopted by leading Fortune 500 healthcare organizations across USA. Hindsait has received multiple accolades and recognitions including prestigious Gartner’s “Cool vendor in AI in Healthcare 2017” and “Top 10 Artificial Intelligence Solution Provider 2018” by Healthcare Tech Outlook, among others.

closepopup
Chris Fuller, Ph.D.VP Informatics, Caribou Biosciences

As the Vice President of Informatics, Chris leads the informatics and software efforts at Caribou Biosciences. He has a background managing diverse teams in developing instrumentation, medical devices, software, and microfluidic systems. Prior to joining Caribou in 2014, he held research and leadership positions in consulting, startup, and established company environments, including Signature Bioscience, MDS Sciex, and Triple Ring Technologies. He led the development of the CellKey instrument for MDS Sciex from its inception through to product launch. Chris is an inventor of multiple patents and patent applications. He received his B.S. and M.S. degrees in Electrical Engineering from the Georgia Institute of Technology and a Ph.D. in Bioinformatics from the University of California, San Francisco.

Chris Fuller, Ph.D.VP Informatics, Caribou Biosciences

As the Vice President of Informatics, Chris leads the informatics and software efforts at Caribou Biosciences. He has a background managing diverse teams in developing instrumentation, medical devices, software, and microfluidic systems. Prior to joining Caribou in 2014, he held research and leadership positions in consulting, startup, and established company environments, including Signature Bioscience, MDS Sciex, and Triple Ring Technologies. He led the development of the CellKey instrument for MDS Sciex from its inception through to product launch. Chris is an inventor of multiple patents and patent applications. He received his B.S. and M.S. degrees in Electrical Engineering from the Georgia Institute of Technology and a Ph.D. in Bioinformatics from the University of California, San Francisco.

closepopup
Sam King, MPH, MBAChair, Digital Healthcare, UC Irvin

Sam is a seasoned healthcare executive, faculty and consultant with 30 years of experience in
health IT, healthcare finance, big data analytics, artificial intelligence and continuous quality
improvement, serving as COO, CIO, VP of Analytics, Senior Director, Director of
Medical/Healthcare Informatics, etc. He is a faculty at UC Irvine Merage School of Business and
USC Price School of Public Policy.
Sam currently is the Chief Information and Innovation Officer for a healthcare startup, and
serves as Chief AI Evangelist and Strategic Adviser for AI Med. He has served in many HFMA
national, regional and chapter leadership roles (including HFMA National Advisory Council,
Southern California Chapter President, National Board of Examiners, National CHFP Exam
Standard Setting Committee, and Yerger judge, Region 11 Education Committee Co‐Chair and
Chair). Additionally, He served as President of HIMSS Southern California Chapter with over
3,000 members, Chair of the HIMSS National Chapters Task Force, and on HIMSS National
Davies Committee on the use of HIT and EHRs. He received HFMA Bronze, Silver, Gold, and
Medal of Honor, and several Yerger Special Recognition awards. He received the 2012 HIMSS
National Chapter Leader of the Year Award. Under his presidency HIMSS SoCal chapter received
HIMSS National Chapter of the Year award in 2011. He is a frequent speaker/moderator at
international, national and professional conferences addressing health IT and healthcare
finance challenges facing our society. He provides training and consulting for healthcare leaders
in the U.S. and around the world.
Sam has active memberships in American College of Healthcare Executives (ACHE), College of
Healthcare Information Management Executives (CHIME), Healthcare Financial Management
Association (HFMA), Healthcare Information and Management Systems Society (HIMSS), and
Healthcare Data and Analytics Association (HDAA). He is a New Venture Competition judge at
UC Irvine and serves as an executive mentor for MBA students.

Sam King, MPH, MBAChair, Digital Healthcare, UC Irvin

Sam is a seasoned healthcare executive, faculty and consultant with 30 years of experience in
health IT, healthcare finance, big data analytics, artificial intelligence and continuous quality
improvement, serving as COO, CIO, VP of Analytics, Senior Director, Director of
Medical/Healthcare Informatics, etc. He is a faculty at UC Irvine Merage School of Business and
USC Price School of Public Policy.
Sam currently is the Chief Information and Innovation Officer for a healthcare startup, and
serves as Chief AI Evangelist and Strategic Adviser for AI Med. He has served in many HFMA
national, regional and chapter leadership roles (including HFMA National Advisory Council,
Southern California Chapter President, National Board of Examiners, National CHFP Exam
Standard Setting Committee, and Yerger judge, Region 11 Education Committee Co‐Chair and
Chair). Additionally, He served as President of HIMSS Southern California Chapter with over
3,000 members, Chair of the HIMSS National Chapters Task Force, and on HIMSS National
Davies Committee on the use of HIT and EHRs. He received HFMA Bronze, Silver, Gold, and
Medal of Honor, and several Yerger Special Recognition awards. He received the 2012 HIMSS
National Chapter Leader of the Year Award. Under his presidency HIMSS SoCal chapter received
HIMSS National Chapter of the Year award in 2011. He is a frequent speaker/moderator at
international, national and professional conferences addressing health IT and healthcare
finance challenges facing our society. He provides training and consulting for healthcare leaders
in the U.S. and around the world.
Sam has active memberships in American College of Healthcare Executives (ACHE), College of
Healthcare Information Management Executives (CHIME), Healthcare Financial Management
Association (HFMA), Healthcare Information and Management Systems Society (HIMSS), and
Healthcare Data and Analytics Association (HDAA). He is a New Venture Competition judge at
UC Irvine and serves as an executive mentor for MBA students.

closepopup
Kam HosnVP, Everest, Co-Founder, Rezvani Motors

Kam Hosn is VP of Development and founding partner of Everest Solutions Group (www.esgnetwork.com), based in Irvine, California. Everest's clients, which are leading Fortune 500 companies, provide turnkey development, engineering, and support services in the areas of desktop/mobile application development, Cloud computing, database, data warehouse, big data, and other enterprise-level development, including overall project management.

Cisco Systems is one client Everest supports. Everest is responsible for a number of key projects for Cisco, including the development of the entire UI framework for a consumer product, MediaHub, which received several awards at the 2008 CES. Everest also developed the first media player mobile app on iPhone and Android for Cisco's Consumer Division, which was showcased to key corporate clients such as T-Mobile, DirectTV, and Disney. Everest, under contract with another Fortune 500 client, has recently finished the development of an essential software application with scheduled worldwide distribution and over 10 million projected downloads. In addition, Everest is currently engaged in the development of software for a multibillion-dollar medical device company to help bring new innovation to the healthcare industry.

Kam is also part of Cisco's Advanced Architecture and Research Group, which is involved in developing leading-edge technologies such as Connected Car. Prior to Cisco Systems, Kam provided database optimization and architecture for corporate clients such as Experian, HR-Block/Option One, Northrop Grumman, Toshiba, and Toyota.

Kam HosnVP, Everest, Co-Founder, Rezvani Motors

Kam Hosn is VP of Development and founding partner of Everest Solutions Group (www.esgnetwork.com), based in Irvine, California. Everest's clients, which are leading Fortune 500 companies, provide turnkey development, engineering, and support services in the areas of desktop/mobile application development, Cloud computing, database, data warehouse, big data, and other enterprise-level development, including overall project management.

Cisco Systems is one client Everest supports. Everest is responsible for a number of key projects for Cisco, including the development of the entire UI framework for a consumer product, MediaHub, which received several awards at the 2008 CES. Everest also developed the first media player mobile app on iPhone and Android for Cisco's Consumer Division, which was showcased to key corporate clients such as T-Mobile, DirectTV, and Disney. Everest, under contract with another Fortune 500 client, has recently finished the development of an essential software application with scheduled worldwide distribution and over 10 million projected downloads. In addition, Everest is currently engaged in the development of software for a multibillion-dollar medical device company to help bring new innovation to the healthcare industry.

Kam is also part of Cisco's Advanced Architecture and Research Group, which is involved in developing leading-edge technologies such as Connected Car. Prior to Cisco Systems, Kam provided database optimization and architecture for corporate clients such as Experian, HR-Block/Option One, Northrop Grumman, Toshiba, and Toyota.

closepopup
Tatyana KanzaveliFounder & CEO of Open Health Network; Blockchain In Healthcare

Tatyana Kanzaveli has gone from a programmer to senior executive at Big 5 to founder and CEO of a startup company along her 20 year career,recognized as a thought leader, mentor for her ability to guide Fortune 500 and startup companies through business challenges.

She’s worked for major companies like PricewaterhouseCoopers and Fujitsu and startups in the early days of the Web.

Tatyana has personally helped companies jump from 0 to millions in revenue even during the toughest economic times. She opened new verticals and markets.

Today she is the founder and CEO of Open Health Network, the startup in a Big Data/Healthcare space. She is a mentor at 500Startups and Richard Branson Entrepreneurs Centre and serves on boards for private companies. She also is licensee and organizer of highly notable TEDxBayArea conferences, she is a frequent speaker at US and International conferences on innovation, entrepreneurship and digital health.

Tatyana has been featured in the White House blog , spoke at the United Nations, presented at the first White House Demo Day hosted by the President Obama.

Tatyana has been recognized as one of the top 10 Influential Women in Healthcare IT in 2015.

Tatyana was USSR chess champion, played in the same team with Gary Kasparov, she loves to cook and kayak.

Tatyana KanzaveliFounder & CEO of Open Health Network; Blockchain In Healthcare

Tatyana Kanzaveli has gone from a programmer to senior executive at Big 5 to founder and CEO of a startup company along her 20 year career,recognized as a thought leader, mentor for her ability to guide Fortune 500 and startup companies through business challenges.

She’s worked for major companies like PricewaterhouseCoopers and Fujitsu and startups in the early days of the Web.

Tatyana has personally helped companies jump from 0 to millions in revenue even during the toughest economic times. She opened new verticals and markets.

Today she is the founder and CEO of Open Health Network, the startup in a Big Data/Healthcare space. She is a mentor at 500Startups and Richard Branson Entrepreneurs Centre and serves on boards for private companies. She also is licensee and organizer of highly notable TEDxBayArea conferences, she is a frequent speaker at US and International conferences on innovation, entrepreneurship and digital health.

Tatyana has been featured in the White House blog , spoke at the United Nations, presented at the first White House Demo Day hosted by the President Obama.

Tatyana has been recognized as one of the top 10 Influential Women in Healthcare IT in 2015.

Tatyana was USSR chess champion, played in the same team with Gary Kasparov, she loves to cook and kayak.

closepopup
Onno FaberFounder, RDMD, Patient Advocate

Four years ago, I started experiencing hearing loss in my left ear. Doctors prescribed me steroids, thinking it was an infection, but the deterioration did not slow down. After numerous failed treatments, a specialist finally ordered an MRI, whereupon he discovered a large tumor on my left hearing nerve. Months later, another tumor was discovered in my right hearing nerve, and another on my spine. I was diagnosed with a rare genetic disease called NF2 (Neurofibromatosis Type 2), a disease that affects only 1 in 30,000 people. It completely changed my perspective.

All my life, I’ve been a technology entrepreneur, beginning with a tech company I started in high school. I’m now applying everything I’ve learned throughout my career to build RDMD, where we’re helping to accelerate treatments for patients with rare disease. Our mission is ambitious, but I can’t imagine working on anything more important than this.

About RDMD

RDMD is on a mission to accelerate treatments for patients with a rare disease, affecting 1 in 10 people worldwide. Rare disease patients suffer from a lack of treatment options because a smaller patient group means fewer resources are devoted to the development of treatments. The main challenge is that pharma companies cannot get efficient access to the data needed to bring therapies to market. Patients, however, are highly motivated to contribute, as their lives are at stake and no other options are available. We work on behalf of patients to generate regulatory-grade clinical and molecular data in a central place.

By generating the data proactively–before the next phase of a clinical trial or even before a pharmaceutical program exists–we can de-risk and speed up the entire clinical trial process (currently the probability of success in orphan diseases is a mere 13.5%). Since we invest in the disease area itself, agnostic from any drug in particular, we can leverage the same data for multiple therapeutic candidates.

Onno FaberFounder, RDMD, Patient Advocate

Four years ago, I started experiencing hearing loss in my left ear. Doctors prescribed me steroids, thinking it was an infection, but the deterioration did not slow down. After numerous failed treatments, a specialist finally ordered an MRI, whereupon he discovered a large tumor on my left hearing nerve. Months later, another tumor was discovered in my right hearing nerve, and another on my spine. I was diagnosed with a rare genetic disease called NF2 (Neurofibromatosis Type 2), a disease that affects only 1 in 30,000 people. It completely changed my perspective.

All my life, I’ve been a technology entrepreneur, beginning with a tech company I started in high school. I’m now applying everything I’ve learned throughout my career to build RDMD, where we’re helping to accelerate treatments for patients with rare disease. Our mission is ambitious, but I can’t imagine working on anything more important than this.

About RDMD

RDMD is on a mission to accelerate treatments for patients with a rare disease, affecting 1 in 10 people worldwide. Rare disease patients suffer from a lack of treatment options because a smaller patient group means fewer resources are devoted to the development of treatments. The main challenge is that pharma companies cannot get efficient access to the data needed to bring therapies to market. Patients, however, are highly motivated to contribute, as their lives are at stake and no other options are available. We work on behalf of patients to generate regulatory-grade clinical and molecular data in a central place.

By generating the data proactively–before the next phase of a clinical trial or even before a pharmaceutical program exists–we can de-risk and speed up the entire clinical trial process (currently the probability of success in orphan diseases is a mere 13.5%). Since we invest in the disease area itself, agnostic from any drug in particular, we can leverage the same data for multiple therapeutic candidates.

closepopup
Sanjit Singh Dang, PhDVC ( Ex-Intel Capital), Founder, U First Capital, Advisor, Google

Sanjit has been a successful Venture Capitalist, Corporate Executive, Board Member, Speaker and Writer in Silicon Valley for almost two decades. He is currently the Co-Founder and Chairman of U First Capital which provides Venture Capital as a Service to Corporations. Till 2018, he was at Intel Capital where he had an excellent track record of driving 1 Exit every year: DocuSign (IPO 2018), Body Labs (Acquired by Amazon in 2017), VokeVR (Acquired by Intel in 2016), Maginatics (Acquired by EMC in 2015) and Basis Science (Acquired by Intel in 2014). He has been an Investor and Board Member of several companies, including True Fit (AI for eCommerce, raised $100M), Reflektion (AI recommendation for eCommerce, raised $42M), Helpshift (AI-driven Customer Service, raised $39M) and Enlighted (IoT, Acquired by Siemens in 2018). He is also an investor in Mirantis (Cloud Computing), GoodData (SaaS BI) and Arcadia Data (Big Data 2.0).

Sanjit has experience investing in Consumer and Enterprise sectors across several areas: Transportation, Artificial Intelligence, Security, Big Data, IoT, Virtual Reality, eCommerce, etc.

Sanjit has been an Advisor to Richard Branson’s Extreme Tech Challenge and Google Launchpad. Sanjit has been on Hillary Clinton's Tech/Innovation Policy Advisory team. He is on Advisory Council of UN’s World Artificial Intelligence Organization. He has also been on University of California President's Innovation Council. Sanjit has the fastest Eng PhD from University of Illinois (2yrs 9mo after undergrad), which he received in 2000 with top research awards. He also attended the VC Executive program at Haas School of Business, UC Berkeley. He’s an invited Speaker at several top conferences, eg SURGE/WebSummit, TiECon, ShopTalk, McKinsey Leadership Summit, Silicon Valley Open Doors, Global AI conference, etc. He’s a mentor at Stanford and Berkeley’s Entrepreneurship programs.

Sanjit Singh Dang, PhDVC ( Ex-Intel Capital), Founder, U First Capital, Advisor, Google

Sanjit has been a successful Venture Capitalist, Corporate Executive, Board Member, Speaker and Writer in Silicon Valley for almost two decades. He is currently the Co-Founder and Chairman of U First Capital which provides Venture Capital as a Service to Corporations. Till 2018, he was at Intel Capital where he had an excellent track record of driving 1 Exit every year: DocuSign (IPO 2018), Body Labs (Acquired by Amazon in 2017), VokeVR (Acquired by Intel in 2016), Maginatics (Acquired by EMC in 2015) and Basis Science (Acquired by Intel in 2014). He has been an Investor and Board Member of several companies, including True Fit (AI for eCommerce, raised $100M), Reflektion (AI recommendation for eCommerce, raised $42M), Helpshift (AI-driven Customer Service, raised $39M) and Enlighted (IoT, Acquired by Siemens in 2018). He is also an investor in Mirantis (Cloud Computing), GoodData (SaaS BI) and Arcadia Data (Big Data 2.0).

Sanjit has experience investing in Consumer and Enterprise sectors across several areas: Transportation, Artificial Intelligence, Security, Big Data, IoT, Virtual Reality, eCommerce, etc.

Sanjit has been an Advisor to Richard Branson’s Extreme Tech Challenge and Google Launchpad. Sanjit has been on Hillary Clinton's Tech/Innovation Policy Advisory team. He is on Advisory Council of UN’s World Artificial Intelligence Organization. He has also been on University of California President's Innovation Council. Sanjit has the fastest Eng PhD from University of Illinois (2yrs 9mo after undergrad), which he received in 2000 with top research awards. He also attended the VC Executive program at Haas School of Business, UC Berkeley. He’s an invited Speaker at several top conferences, eg SURGE/WebSummit, TiECon, ShopTalk, McKinsey Leadership Summit, Silicon Valley Open Doors, Global AI conference, etc. He’s a mentor at Stanford and Berkeley’s Entrepreneurship programs.

closepopup
Greg BerkinManaging Director, Concours Ventures

Entrepreneur, CEO, start-up guru, loaner C-level executive, software maven, apps builder, company founder, venture capital angel group, board member, MBA, angel, advisor, digital media, team builder, director

Specialties: Software/Hardware, Programming, Cyber Security, AR/VR, Internet Applications, Social Media, Digital Rights Management, Intellectual Property, Media Creation, Marketing & Publishing, Media Financing, Technology, Directing, Producing, Finance, Investment, M&A

Greg BerkinManaging Director, Concours Ventures

Entrepreneur, CEO, start-up guru, loaner C-level executive, software maven, apps builder, company founder, venture capital angel group, board member, MBA, angel, advisor, digital media, team builder, director

Specialties: Software/Hardware, Programming, Cyber Security, AR/VR, Internet Applications, Social Media, Digital Rights Management, Intellectual Property, Media Creation, Marketing & Publishing, Media Financing, Technology, Directing, Producing, Finance, Investment, M&A

closepopup
Kris VulganCo-founder, Ferocity Capital

Kris Vulgan kickstarted her career in politics as a speechwriter for the Prime Minister of Slovakia during her Master's degree education in political psychology. Later she co-founded a Slovakian political party that gained 10% of parliament seats in the span of merely two years. After a couple years of studying politics in London, in 2008 she moved to Silicon Valley for a job at Cisco, and worked for other top Fortune 100 companies (VMware, Apple, Informatica, Google). Kris spent the last two years working with a few family offices investors as an adviser for product strategy. She helped set up Silicon Valley office for a Chinese investment company InTeahouse, bringing global startups to China. In June 2018 she co-founded Ferocity Capital where is is a Managing Partner.

Kris VulganCo-founder, Ferocity Capital

Kris Vulgan kickstarted her career in politics as a speechwriter for the Prime Minister of Slovakia during her Master's degree education in political psychology. Later she co-founded a Slovakian political party that gained 10% of parliament seats in the span of merely two years. After a couple years of studying politics in London, in 2008 she moved to Silicon Valley for a job at Cisco, and worked for other top Fortune 100 companies (VMware, Apple, Informatica, Google). Kris spent the last two years working with a few family offices investors as an adviser for product strategy. She helped set up Silicon Valley office for a Chinese investment company InTeahouse, bringing global startups to China. In June 2018 she co-founded Ferocity Capital where is is a Managing Partner.

closepopup
Jin ZhangInvestment Manager, Tsingyuan Ventures

Jin is an investment manager helping businesses grow in the Chinese Pharmaceutical market. She has following skillsets:
• M.D. with Ph.D. training in Pharmacology
• Extensively experienced in developing novel biologics therapeutics
• Strong expertise in introducing and marketing products in the Chinese market
• Editor at Pharma Executive, The Pharmaceutical Consultant, etc.
• Successful track-record on project management and sale generation
• Leadership role in the local life science community
• Clinical experience in multiple therapeutic areas, including immunology, cardiology, and oncology

Jin ZhangInvestment Manager, Tsingyuan Ventures

Jin is an investment manager helping businesses grow in the Chinese Pharmaceutical market. She has following skillsets:
• M.D. with Ph.D. training in Pharmacology
• Extensively experienced in developing novel biologics therapeutics
• Strong expertise in introducing and marketing products in the Chinese market
• Editor at Pharma Executive, The Pharmaceutical Consultant, etc.
• Successful track-record on project management and sale generation
• Leadership role in the local life science community
• Clinical experience in multiple therapeutic areas, including immunology, cardiology, and oncology

closepopup
Alex J. Zhang, PhD, MBAInvestment Executive, Hanhai Biolabs, Inc.

Alex is M&A and investment executive with extensive experience and network in life sciences.

Alex J. Zhang, PhD, MBAInvestment Executive, Hanhai Biolabs, Inc.

Alex is M&A and investment executive with extensive experience and network in life sciences.

closepopup
Nitin PachisiaFounding Partner at Unshackled Ventures

Nitin is a founding partner of Unshackled Ventures, the only early stage venture fund designed specifically for immigrant founded startups. We are on a mission to create 100,000 American jobs by helping immigrant founders succeed faster.

Before starting Unshackled Ventures, Nitin founded an experiential ecommerce company. Prior to that, he ran finance and strategy for ed-tech startup Kno (acquired by Intel) that raised over $90M of funding from top VC’s including Andreessen Horowitz, First Round Capital and Floodgate. Before Kno, Nitin worked at Deloitte, focusing on tech startups and helping them with growth, exits, and strategic initiatives.

Nitin has appeared on NBC, NPR, CCTV, has been featured in various publications including Forbes, WSJ, Financial Times, Techcrunch, CNN, and has been an op-ed contributor in the Huffington Post and ReCode. Nitin is actively engaged as mentor or evaluation committee member at Stanford University, Babson, Alchemist Accelerator, GTWY, Founder Institute, among others.

Being an immigrant himself and having founded startups while on a visa in U.S., Nitin understands the venture resources immigrant founders need, besides capital. He recognizes the opportunity immigrant founders represent and is focused on building an ecosystem that strengthens the pursuit of their American dream.

Nitin PachisiaFounding Partner at Unshackled Ventures

Nitin is a founding partner of Unshackled Ventures, the only early stage venture fund designed specifically for immigrant founded startups. We are on a mission to create 100,000 American jobs by helping immigrant founders succeed faster.

Before starting Unshackled Ventures, Nitin founded an experiential ecommerce company. Prior to that, he ran finance and strategy for ed-tech startup Kno (acquired by Intel) that raised over $90M of funding from top VC’s including Andreessen Horowitz, First Round Capital and Floodgate. Before Kno, Nitin worked at Deloitte, focusing on tech startups and helping them with growth, exits, and strategic initiatives.

Nitin has appeared on NBC, NPR, CCTV, has been featured in various publications including Forbes, WSJ, Financial Times, Techcrunch, CNN, and has been an op-ed contributor in the Huffington Post and ReCode. Nitin is actively engaged as mentor or evaluation committee member at Stanford University, Babson, Alchemist Accelerator, GTWY, Founder Institute, among others.

Being an immigrant himself and having founded startups while on a visa in U.S., Nitin understands the venture resources immigrant founders need, besides capital. He recognizes the opportunity immigrant founders represent and is focused on building an ecosystem that strengthens the pursuit of their American dream.

closepopup
Huijun Zhou, PhDCo-founder of Doctor Chain and iDNA.com.cn

Dr. Huijun Zhou Ring is founder of Doctor Chain and iDNA.com.cn, a precision medicine company. Dr. Ring received her Ph.D. in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at the Stanford University School of Medicine. She is a clinical molecular geneticist, board-certified by the American Board of Medical Genetics, and a fellow of the American College of Medical Genetics. Dr Huijun Ring is also an investor in genomic technology companies, with a focus on China and the US. iDNA was recognized by the Deloitte Technology Fast 50 program™ in 2015 and 2016 as one of China's leading fast growing biotech companies. iDNA offers next generation DNA and ctDNA sequencing, instruments and personalized drug development programs.

Huijun Zhou, PhDCo-founder of Doctor Chain and iDNA.com.cn

Dr. Huijun Zhou Ring is founder of Doctor Chain and iDNA.com.cn, a precision medicine company. Dr. Ring received her Ph.D. in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at the Stanford University School of Medicine. She is a clinical molecular geneticist, board-certified by the American Board of Medical Genetics, and a fellow of the American College of Medical Genetics. Dr Huijun Ring is also an investor in genomic technology companies, with a focus on China and the US. iDNA was recognized by the Deloitte Technology Fast 50 program™ in 2015 and 2016 as one of China's leading fast growing biotech companies. iDNA offers next generation DNA and ctDNA sequencing, instruments and personalized drug development programs.

closepopup
Anitha BebergCEO at Seva Exchange

Anitha Beberg, an alumni of the Silicon Valley Founder Institute, is the Founder and CEO of Seva Exchange, which has recently formalized a series of partnerships with organizations supporting blockchain for social impact and universal basic income, including TimeBanks.org, Mannabase, and Andrew Yang’s 2020 Presidential Campaign.

Seva Exchange is a platform using artificial intelligence and blockchain technologies to galvanize global volunteerism by reinventing timebanking services for the modern digital economy.

Prior to becoming an entrepreneur, Anitha spent a decade in Software Project Management and worked in companies such as Siemens, Sun, Cadence, and HP. After taking time off to raise a family, she spent much of her free time volunteering.

She joined Timebanks.org, the nonprofit that started the timebanking movement. Seva Exchange was formed after Edgar Cahn, (the creator of timebanking) gave her the title of Senior Timebanking Fellow and asked her to start a for-profit timebanking entity that would also support the nonprofit. Anitha wants to use her software background to mainstream timebanking to tackle many societal issues. She understands how blockchain and crypto have been misunderstood and wants to change that perception by partnering with other Crypto for Good companies.

Anitha BebergCEO at Seva Exchange

Anitha Beberg, an alumni of the Silicon Valley Founder Institute, is the Founder and CEO of Seva Exchange, which has recently formalized a series of partnerships with organizations supporting blockchain for social impact and universal basic income, including TimeBanks.org, Mannabase, and Andrew Yang’s 2020 Presidential Campaign.

Seva Exchange is a platform using artificial intelligence and blockchain technologies to galvanize global volunteerism by reinventing timebanking services for the modern digital economy.

Prior to becoming an entrepreneur, Anitha spent a decade in Software Project Management and worked in companies such as Siemens, Sun, Cadence, and HP. After taking time off to raise a family, she spent much of her free time volunteering.

She joined Timebanks.org, the nonprofit that started the timebanking movement. Seva Exchange was formed after Edgar Cahn, (the creator of timebanking) gave her the title of Senior Timebanking Fellow and asked her to start a for-profit timebanking entity that would also support the nonprofit. Anitha wants to use her software background to mainstream timebanking to tackle many societal issues. She understands how blockchain and crypto have been misunderstood and wants to change that perception by partnering with other Crypto for Good companies.

closepopup
Amanjyot S. Johar, MBAEntrepreneur, Advisor, Proteum

Over the last 10 years, Aman has worked with a variety of startups and has been on both sides of the entrepreneur-investor table. With Proteum, Aman is excited about enterprise applications of blockchains and advising companies in building their capabilities to adapt to a rapidly shifting tech landscape. With a background in strategy, operations, and deal-making, Aman focusses on the business and regulatory implications of utilizing blockchains and tokenizing assets. He is a strategic advisor to executives and boards on creating new business models in verticals such as payments, identity management, forex transactions, and real estate to name a few recent engagements. Currently, Aman is a mentor at the Singularity University, a board member at KeraCel, a solid state battery company and at Telewave. Previously, Aman co-founded Applied Protein which was acquired by Pivot Pharma. He holds a B.Tech in Electrical Engineering from the Indian Institute of Technology, BHU and an MBA from the Tepper School of Business at Carnegie Mellon where he was named a Swartz Fellow for entrepreneurship. In his spare time, Aman enjoys teaching photography and golf to his kids.

Amanjyot S. Johar, MBAEntrepreneur, Advisor, Proteum

Over the last 10 years, Aman has worked with a variety of startups and has been on both sides of the entrepreneur-investor table. With Proteum, Aman is excited about enterprise applications of blockchains and advising companies in building their capabilities to adapt to a rapidly shifting tech landscape. With a background in strategy, operations, and deal-making, Aman focusses on the business and regulatory implications of utilizing blockchains and tokenizing assets. He is a strategic advisor to executives and boards on creating new business models in verticals such as payments, identity management, forex transactions, and real estate to name a few recent engagements. Currently, Aman is a mentor at the Singularity University, a board member at KeraCel, a solid state battery company and at Telewave. Previously, Aman co-founded Applied Protein which was acquired by Pivot Pharma. He holds a B.Tech in Electrical Engineering from the Indian Institute of Technology, BHU and an MBA from the Tepper School of Business at Carnegie Mellon where he was named a Swartz Fellow for entrepreneurship. In his spare time, Aman enjoys teaching photography and golf to his kids.

closepopup
Nethaji TummuruBlockchain Entrepreneur, Mentor, ex-SAP

Nethaji, is the founder of stealth mode Blockchain startup focusing on building tooling and ecosystem to make Blockchain development seamless. During his time at SAP, he conceptualized and delivered TrueRec by SAP, A self-sovereign identity platform leveraging Blockchain to manage user's identity.

Nethaji TummuruBlockchain Entrepreneur, Mentor, ex-SAP

Nethaji, is the founder of stealth mode Blockchain startup focusing on building tooling and ecosystem to make Blockchain development seamless. During his time at SAP, he conceptualized and delivered TrueRec by SAP, A self-sovereign identity platform leveraging Blockchain to manage user's identity.

closepopup
Tony PerkinsFounder Cryptonite Ventures

Tony Perkins is a Venture Partner with DFJ Frontier. He is the creator and former editor-in-chief of Red Herring magazine and the CEO of AlwaysOn, an interactive online network for technology insiders. Perkins co-authored "The Internet Bubble: Inside the Overvalued World of High-Tech Stocks", a book that foretold the dot-com bust.

Perkins served on President George W. Bush's Information Technology Advisory Council and he was the founding chairman of the Churchill Club in Palo Alto, California, for which he received the Ernst & Young Entrepreneur of the Year Award.

He has been a member of the World Economic Forum's Media Leaders group since 1996. Perkins was also founder and CEO of Upside Publishing and Vice President of Business Development at Silicon Valley Bank.

Perkins continues to chronicle the technology world in a regular column for the Wall Street Journal and as television commentator for MSNBC's Hardball with Chris Matthews, CNN, CNBC, BBC, and Bloomberg Television.

Tony Perkins graduated from UC Davis with a BA in Western European History/Political Science.

Tony PerkinsFounder Cryptonite Ventures

Tony Perkins is a Venture Partner with DFJ Frontier. He is the creator and former editor-in-chief of Red Herring magazine and the CEO of AlwaysOn, an interactive online network for technology insiders. Perkins co-authored "The Internet Bubble: Inside the Overvalued World of High-Tech Stocks", a book that foretold the dot-com bust.

Perkins served on President George W. Bush's Information Technology Advisory Council and he was the founding chairman of the Churchill Club in Palo Alto, California, for which he received the Ernst & Young Entrepreneur of the Year Award.

He has been a member of the World Economic Forum's Media Leaders group since 1996. Perkins was also founder and CEO of Upside Publishing and Vice President of Business Development at Silicon Valley Bank.

Perkins continues to chronicle the technology world in a regular column for the Wall Street Journal and as television commentator for MSNBC's Hardball with Chris Matthews, CNN, CNBC, BBC, and Bloomberg Television.

Tony Perkins graduated from UC Davis with a BA in Western European History/Political Science.

closepopup
Hermann Schindler, PhD, MBACEO, Scalator Ventures

Dr. Hermann Schindler, CEO of Scalator Ventures / Investor in Health Solutions based on Artificial Intelligence and Edge Computing. Experienced executive with a proven track record in venture investment, M&A, building new companies, business models, solutions and innovation based on artificial intelligence, first- of-a-kinds, platforms and ecosystem. 360 degree view and experience on startups and ventures from senior leadership positions in big global tech-companies, strategy consulting, as investor, founder and in corporate venture financing responsibilities. Different own registered patents, leadership and innovation awards. Focus areas in health are the diseases of the aging population like stroke, Parkinson, Alzheimer and Orthopedics.

Hermann Schindler, PhD, MBACEO, Scalator Ventures

Dr. Hermann Schindler, CEO of Scalator Ventures / Investor in Health Solutions based on Artificial Intelligence and Edge Computing. Experienced executive with a proven track record in venture investment, M&A, building new companies, business models, solutions and innovation based on artificial intelligence, first- of-a-kinds, platforms and ecosystem. 360 degree view and experience on startups and ventures from senior leadership positions in big global tech-companies, strategy consulting, as investor, founder and in corporate venture financing responsibilities. Different own registered patents, leadership and innovation awards. Focus areas in health are the diseases of the aging population like stroke, Parkinson, Alzheimer and Orthopedics.

closepopup
Lela Mirtskhulava, PhDAssociate Professor at San Jose State University

Dr. Mirtskhulava currently is an Associate Professor (Part time) in the department of Computer engineering at San Jose State University, CA. She concurrently holds an associate professor position at the department of Computer Science at Ivane Javakhishvili Tbilisi State University and San Diego State University Georgia. Dr. Mirtskhulava received her Ph.D. in Computers, Complexes, Systems and Networks. She has served in various capacities at several Georgian universities and has 15 years of industry work experience as an ICT Senior Engineer at Ericsson Ltd and Geocell LLC, Georgia. Her research interests include: ANN modeling for stroke diagnosis, medical applications of ANN, mobile app development, IoT security issues, mathematical modeling and wireless technologies. Dr. Mirtskhulava’s experience in this realm of artificial intelligence is unique. She was the first who developed an artificial intelligence capable of diagnosing stroke patients. Her prototype of an artificial intelligence distinguishes between stroke patients and normal subjects with > 99% accuracy. Dr. Mirtskhulava has published over 50 scientific papers in the areas of medical applications of ANN, network security, mathematical modeling, mobile app development.

Dr. Mirtskhulava was invited to the the University of Cambrige, UK to conduct the scientific workshops in 2013. She is the recipient of DAAD Scholarship Certificate in scope of Academic staff exchange program, at Westsaxson University of Applied Sciences Zwickau, Germany in 2016. Dr. Mirtskhulava has participated in Professor Exchange program to San Diego State University. She was a keynote speaker and served as the technical Committee and advisory board member in several international conferences.

Lela Mirtskhulava, PhDAssociate Professor at San Jose State University

Dr. Mirtskhulava currently is an Associate Professor (Part time) in the department of Computer engineering at San Jose State University, CA. She concurrently holds an associate professor position at the department of Computer Science at Ivane Javakhishvili Tbilisi State University and San Diego State University Georgia. Dr. Mirtskhulava received her Ph.D. in Computers, Complexes, Systems and Networks. She has served in various capacities at several Georgian universities and has 15 years of industry work experience as an ICT Senior Engineer at Ericsson Ltd and Geocell LLC, Georgia. Her research interests include: ANN modeling for stroke diagnosis, medical applications of ANN, mobile app development, IoT security issues, mathematical modeling and wireless technologies. Dr. Mirtskhulava’s experience in this realm of artificial intelligence is unique. She was the first who developed an artificial intelligence capable of diagnosing stroke patients. Her prototype of an artificial intelligence distinguishes between stroke patients and normal subjects with > 99% accuracy. Dr. Mirtskhulava has published over 50 scientific papers in the areas of medical applications of ANN, network security, mathematical modeling, mobile app development.

Dr. Mirtskhulava was invited to the the University of Cambrige, UK to conduct the scientific workshops in 2013. She is the recipient of DAAD Scholarship Certificate in scope of Academic staff exchange program, at Westsaxson University of Applied Sciences Zwickau, Germany in 2016. Dr. Mirtskhulava has participated in Professor Exchange program to San Diego State University. She was a keynote speaker and served as the technical Committee and advisory board member in several international conferences.

closepopup
Trevor Hallstein, CFAHealthcare Product Lead, Swish Labs

Trevor is a Silicon Valley based Product Manager focusing on AI and Data Science in the Healthcare Industry, and currently serves as the Healthcare Product Lead at Swish Labs. Over the last several years he ran AI and Data Science projects for enterprises such as eBay, McDonald's, and Prudential. He previously served as COO & Director of Research for a multibillion dollar hedge fund and as EVP, Operations for a late stage startup ($10M Series A, now in 10th year of business). Trevor studied mathematics at Pomona College.

Trevor Hallstein, CFAHealthcare Product Lead, Swish Labs

Trevor is a Silicon Valley based Product Manager focusing on AI and Data Science in the Healthcare Industry, and currently serves as the Healthcare Product Lead at Swish Labs. Over the last several years he ran AI and Data Science projects for enterprises such as eBay, McDonald's, and Prudential. He previously served as COO & Director of Research for a multibillion dollar hedge fund and as EVP, Operations for a late stage startup ($10M Series A, now in 10th year of business). Trevor studied mathematics at Pomona College.

closepopup
Niki GastinelData Scientist, President of CSPA

Niki currently serves as the President of California Software Professional Association (CSPA.com), a 501(c)3 organization dedicated to promoting leadership, community and entrepreneurship. Niki has worked as a software engineer and leader for tech giants such as Apple, SAP and as well as startups in Silicon Valley. She has deep and broad knowledge in big data and business intelligence. She was the 1st investor in Viditure.com and helped to build the core team and the initial product. Niki believes in using technology and innovation to improve human conditions.

Niki received her B.S. in Computer Science from University of Science and Technology of China and M.S. in Data Science from Carnegie-Mellon University.

Niki GastinelData Scientist, President of CSPA

Niki currently serves as the President of California Software Professional Association (CSPA.com), a 501(c)3 organization dedicated to promoting leadership, community and entrepreneurship. Niki has worked as a software engineer and leader for tech giants such as Apple, SAP and as well as startups in Silicon Valley. She has deep and broad knowledge in big data and business intelligence. She was the 1st investor in Viditure.com and helped to build the core team and the initial product. Niki believes in using technology and innovation to improve human conditions.

Niki received her B.S. in Computer Science from University of Science and Technology of China and M.S. in Data Science from Carnegie-Mellon University.

closepopup
Manoj KenkareManaging Director, Accenture

Seasoned executive and most Trusted advisor! Well networked executive within SF bay area with relationships in North America and beyond. During his career Manoj has worked on several transformation deals with Fortune 100 companies and some key institutions like The Whitehouse, FDA, NIH and CDC. Key areas of focus Strategy, AI, SAP/Oracle/ERP applications, Analytics and Data Sciences, Mobility, Workday, Cloud and Portal strategies among others.

Manoj KenkareManaging Director, Accenture

Seasoned executive and most Trusted advisor! Well networked executive within SF bay area with relationships in North America and beyond. During his career Manoj has worked on several transformation deals with Fortune 100 companies and some key institutions like The Whitehouse, FDA, NIH and CDC. Key areas of focus Strategy, AI, SAP/Oracle/ERP applications, Analytics and Data Sciences, Mobility, Workday, Cloud and Portal strategies among others.

closepopup
Takashi Isobe, PhDSenior Researcher at Hitachi America, Ltd.

Takashi is a senior researcher at Hitachi America, Ltd. He is the lead scientist in Rehabilitation AI platform that was just launched by Hitachi. Takashi will present the Rehabilitation AI platform at DANS 2019.

Takashi Isobe, PhDSenior Researcher at Hitachi America, Ltd.

Takashi is a senior researcher at Hitachi America, Ltd. He is the lead scientist in Rehabilitation AI platform that was just launched by Hitachi. Takashi will present the Rehabilitation AI platform at DANS 2019.

closepopup
Sharon ZhouPhD Student, Stanford (with Michael Bernstein & Andrew Ng)

Sharon is innovating on and deploying deep learning models in her PhD at Stanford with Andrew Ng and Michael Bernstein, with a focus on healthcare. She has published award-winning research to top computer science venues. Prior to this, she had joined and consulted several high-tech companies, most notably Google, as a product manager in machine learning and artificial intelligence. She graduated summa cum laude in Classics and Computer Science from Harvard College in 2015.

Sharon ZhouPhD Student, Stanford (with Michael Bernstein & Andrew Ng)

Sharon is innovating on and deploying deep learning models in her PhD at Stanford with Andrew Ng and Michael Bernstein, with a focus on healthcare. She has published award-winning research to top computer science venues. Prior to this, she had joined and consulted several high-tech companies, most notably Google, as a product manager in machine learning and artificial intelligence. She graduated summa cum laude in Classics and Computer Science from Harvard College in 2015.

closepopup
Praful Krishna, MBACEO, Coseer

Praful helps teams in Fortune 500 and Government to automate tedious, boring, repetitive text based tasks. He is a cognitive computing and AI automation expert and an avid coder, who loves to experiment. Praful founded Coseer after a career with a hedge fund and a turnaround CEO role. Praful is an alumnus of McKinsey, Harvard, and IIT. He is also a hapless dad and lives in San Francisco.

Praful Krishna, MBACEO, Coseer

Praful helps teams in Fortune 500 and Government to automate tedious, boring, repetitive text based tasks. He is a cognitive computing and AI automation expert and an avid coder, who loves to experiment. Praful founded Coseer after a career with a hedge fund and a turnaround CEO role. Praful is an alumnus of McKinsey, Harvard, and IIT. He is also a hapless dad and lives in San Francisco.

closepopup
Carol Mao, MBAVice President, Fusion Fund

Carol Mao is a Vice President of Fusion Fund. She has extensive experience in US and Asian capital markets. Prior to joining Fusion Fund, she was a senior Investment Banking Associate at Deutsche Bank and CITIC Securities International for over five years. During this time, she participated in or completed more than 15 IPO/M&A/Bond/pre-IPO investment transactions. Carol has an M.B.A. degree from Columbia Business School, a M.S. in Financial Mathematics and Statistics from HKUST and a B.S. in Mathematics from Peking University.

Carol Mao, MBAVice President, Fusion Fund

Carol Mao is a Vice President of Fusion Fund. She has extensive experience in US and Asian capital markets. Prior to joining Fusion Fund, she was a senior Investment Banking Associate at Deutsche Bank and CITIC Securities International for over five years. During this time, she participated in or completed more than 15 IPO/M&A/Bond/pre-IPO investment transactions. Carol has an M.B.A. degree from Columbia Business School, a M.S. in Financial Mathematics and Statistics from HKUST and a B.S. in Mathematics from Peking University.

closepopup
Simon MacGibbonCEO, Co-Founder, Myia Labs

Simon MacGibbon is the CEO and co-founder of Myia Health, an intelligent virtual health monitoring platform. Myia uses machine learning to transform streams of real-world health data into timely and actionable clinical insights. Simon has 25 years of experience using technology to create data driven products and transform enterprise processes.

Prior to co-founding and leading Myia Health, Simon co-founded the Boston Consulting Group’s Digital Ventures global team. At BCGDV, Simon led teams responsible for imagining, building, and commercializing new technology platforms to help some of the world’s most influential companies innovate with startup like speed. Simon was formerly an Associate Partner at McKinsey & Co. and implemented customer relationship management and analytics technology while at IBM.

Simon has a BSc from Otago University in New Zealand and a BA(Hons) in Applied and Industrial Psychology from the University of Canterbury.

Simon MacGibbonCEO, Co-Founder, Myia Labs

Simon MacGibbon is the CEO and co-founder of Myia Health, an intelligent virtual health monitoring platform. Myia uses machine learning to transform streams of real-world health data into timely and actionable clinical insights. Simon has 25 years of experience using technology to create data driven products and transform enterprise processes.

Prior to co-founding and leading Myia Health, Simon co-founded the Boston Consulting Group’s Digital Ventures global team. At BCGDV, Simon led teams responsible for imagining, building, and commercializing new technology platforms to help some of the world’s most influential companies innovate with startup like speed. Simon was formerly an Associate Partner at McKinsey & Co. and implemented customer relationship management and analytics technology while at IBM.

Simon has a BSc from Otago University in New Zealand and a BA(Hons) in Applied and Industrial Psychology from the University of Canterbury.

closepopup
Lu ZhangFounder, Managing Partner, Fusion Fund

Lu Zhang, Founder and Managing Partner of Fusion Fund. Recently, Lu is selected as 2018 Young Global Leader by the World Economic Forum (Davos). Before this, she also got selected as Silicon Valley Women of Influence 2018 and Top 10 all America Chinese Youth. In 2017, she was awarded the Forbes US 30 under 30 & Featured Honoree of VC category and also awarded as the Town & Country 50 Modern Swans Influencer. Prior to starting Fusion Fund, she was the Founder and CEO of a medical device company (acquired in 2012). Lu is active in the entrepreneur and investor communities providing mentorship and serves as an advisor to programs like Microsoft AC, Singularity University, StartX at Stanford, and Youth Council of Future Forum. Lu received her M.S. in Materials Science and Engineering from Stanford University and holds several patents.

Lu ZhangFounder, Managing Partner, Fusion Fund

Lu Zhang, Founder and Managing Partner of Fusion Fund. Recently, Lu is selected as 2018 Young Global Leader by the World Economic Forum (Davos). Before this, she also got selected as Silicon Valley Women of Influence 2018 and Top 10 all America Chinese Youth. In 2017, she was awarded the Forbes US 30 under 30 & Featured Honoree of VC category and also awarded as the Town & Country 50 Modern Swans Influencer. Prior to starting Fusion Fund, she was the Founder and CEO of a medical device company (acquired in 2012). Lu is active in the entrepreneur and investor communities providing mentorship and serves as an advisor to programs like Microsoft AC, Singularity University, StartX at Stanford, and Youth Council of Future Forum. Lu received her M.S. in Materials Science and Engineering from Stanford University and holds several patents.

closepopup
Julie Harness, PhDAssociate Director, Innovation Services, CLSI

Julie Harness is the Associate Director at CLSI-California Life Sciences Institute. She runs the San Francisco FAST advisory program and supports Heather Shane in running the CARB-X program at the California Life Sciences Institute (CLSI). Prior to joining CLSI, Julie consulted for various bay area and international life sciences companies in areas such as business development operations and strategy, partnerships, acquisition target identification, diligence and landscape analyses. Apropos to the CLSI programs she will be supporting, Julie also gained direct entrepreneurial experience as founder and CEO of Cybelle Biosciences, where she created a human stem cell population for Huntington’s Disease cell therapy. Julie completed her BA in Psychology, Biological Sciences at SJSU, her PhD in the Interdepartmental Neuroscience Program at UCI and Postdoctoral Fellowship in Neuro-Oncology in the UCSF Neurosurgery Dept.

Julie Harness, PhDAssociate Director, Innovation Services, CLSI

Julie Harness is the Associate Director at CLSI-California Life Sciences Institute. She runs the San Francisco FAST advisory program and supports Heather Shane in running the CARB-X program at the California Life Sciences Institute (CLSI). Prior to joining CLSI, Julie consulted for various bay area and international life sciences companies in areas such as business development operations and strategy, partnerships, acquisition target identification, diligence and landscape analyses. Apropos to the CLSI programs she will be supporting, Julie also gained direct entrepreneurial experience as founder and CEO of Cybelle Biosciences, where she created a human stem cell population for Huntington’s Disease cell therapy. Julie completed her BA in Psychology, Biological Sciences at SJSU, her PhD in the Interdepartmental Neuroscience Program at UCI and Postdoctoral Fellowship in Neuro-Oncology in the UCSF Neurosurgery Dept.

closepopup
T. Greg McKelvey Jr. MD, MPHChief Medical Officer at KenSci

Dr. T. Greg McKelvey Jr. MD, MPH, is Chief Medical Officer at KenSci. In his role, Dr. Greg leads doctors and data scientists to identify patterns in patient data to predict risk that can cost-effectively improve care outcomes. Prior to his role at KenSci, Dr. Greg was the medical director at Epsilon. Dr. Greg trained in Plastic & Reconstructive Surgery at the Montefiore Medical Center, and in Occupational & Environmental Medicine and Biomedical & Health Informatics at the University of Washington (UW).

He has also co-authored several publications like Predicting future frequent users of emergency departments in California state, The design of a medical school social justice curriculum and A detailed analysis of level I evidence (randomized controlled trials and meta-analyses) in five plastic surgery journals to date: 1978 to 2009, to name a few.

Dr. Greg received his Master of Public Health (M.P.H) from the John Hopkins Bloomberg School of Public Health and his Doctor of Medicine (MD) from the Dartmouth Medical School. He is also a member of the board of directors at the YMCA of Greater Seattle.

T. Greg McKelvey Jr. MD, MPHChief Medical Officer at KenSci

Dr. T. Greg McKelvey Jr. MD, MPH, is Chief Medical Officer at KenSci. In his role, Dr. Greg leads doctors and data scientists to identify patterns in patient data to predict risk that can cost-effectively improve care outcomes. Prior to his role at KenSci, Dr. Greg was the medical director at Epsilon. Dr. Greg trained in Plastic & Reconstructive Surgery at the Montefiore Medical Center, and in Occupational & Environmental Medicine and Biomedical & Health Informatics at the University of Washington (UW).

He has also co-authored several publications like Predicting future frequent users of emergency departments in California state, The design of a medical school social justice curriculum and A detailed analysis of level I evidence (randomized controlled trials and meta-analyses) in five plastic surgery journals to date: 1978 to 2009, to name a few.

Dr. Greg received his Master of Public Health (M.P.H) from the John Hopkins Bloomberg School of Public Health and his Doctor of Medicine (MD) from the Dartmouth Medical School. He is also a member of the board of directors at the YMCA of Greater Seattle.

closepopup
Ali Alemozafar, PhD, JD LawPartner-Elect at Wilson Sonsini Goodrich & Rosati

Dr. Ali R. Alemozafar is a partner-elect at Wilson Sonsini Goodrich & Rosati, where he focuses on strategic intellectual property counseling in a wide range of technical fields, including diagnostics, genomics, bioinformatics, artificial intelligence, and materials. His expertise includes patent strategy, patent prosecution, and patent diligence—including freedom-to-operate analyses—for financings, mergers and acquisitions, and public offerings. Ali has prepared and prosecuted patent applications in the United States and other jurisdictions, including Europe, China, and Japan. He provides legal counseling to companies at various stages of growth, from pre-financing start-ups to public companies.

Prior to joining the firm, Ali worked on data warehousing, business intelligence, and enterprise data integration. He frequently lectures at the UC Berkeley School of Law and UC Hastings College of the Law on various intellectual property topics, including patent strategy and IP due diligence.

Ali Alemozafar, PhD, JD LawPartner-Elect at Wilson Sonsini Goodrich & Rosati

Dr. Ali R. Alemozafar is a partner-elect at Wilson Sonsini Goodrich & Rosati, where he focuses on strategic intellectual property counseling in a wide range of technical fields, including diagnostics, genomics, bioinformatics, artificial intelligence, and materials. His expertise includes patent strategy, patent prosecution, and patent diligence—including freedom-to-operate analyses—for financings, mergers and acquisitions, and public offerings. Ali has prepared and prosecuted patent applications in the United States and other jurisdictions, including Europe, China, and Japan. He provides legal counseling to companies at various stages of growth, from pre-financing start-ups to public companies.

Prior to joining the firm, Ali worked on data warehousing, business intelligence, and enterprise data integration. He frequently lectures at the UC Berkeley School of Law and UC Hastings College of the Law on various intellectual property topics, including patent strategy and IP due diligence.

closepopup
Satya Narayan, LLMAttorney at Royse Law Firm

Satya Narayan focuses her practice on domestic and cross-border technology licensing and commercial transactions. Ms. Narayan represents clients ranging from start-ups to established public companies and multinational companies. Her clients include software, e-commerce, cloud, digital media and content, semiconductor, solar, and medical device companies.

Ms. Narayan structures and negotiates distribution, supply, and manufacturing agreements, affiliate and partnering agreements, cloud, SaaS, and e-commerce agreements, consulting and development agreements, and agreements in connection with joint ventures, strategic alliances and spin-outs.

Ms. Narayan's cross-border transactional experience includes India, the European Union, China, and Japan among others.

Ms. Narayan is admitted to practice in California and India.

Satya Narayan, LLMAttorney at Royse Law Firm

Satya Narayan focuses her practice on domestic and cross-border technology licensing and commercial transactions. Ms. Narayan represents clients ranging from start-ups to established public companies and multinational companies. Her clients include software, e-commerce, cloud, digital media and content, semiconductor, solar, and medical device companies.

Ms. Narayan structures and negotiates distribution, supply, and manufacturing agreements, affiliate and partnering agreements, cloud, SaaS, and e-commerce agreements, consulting and development agreements, and agreements in connection with joint ventures, strategic alliances and spin-outs.

Ms. Narayan's cross-border transactional experience includes India, the European Union, China, and Japan among others.

Ms. Narayan is admitted to practice in California and India.

closepopup
Stephen Wurzburg, JDPartner, Pillsbury Winthrop Shaw Pittman LLP

Pillsbury Corporate partner Stephen Wurzburg is a trusted adviser to emerging growth and large corporations, often guiding clients through transformative, multimillion-dollar M&As and IP transactions.

Steve represents many high-tech and consumer product companies that develop, manufacture or distribute computer hardware, laser, telecommunications, chemical and solar energy products and have Software as a Service (SaaS) and App offerings. Experienced in corporation, LLC, partnership, securities, antitrust, tax, UCC and international law, he serves as outside counsel to small companies and partners with larger clients’ in-house counsel. Steve handles financing and stock liquidity matters; selling and licensing products and services; protecting and monetizing IP assets; executive and employee compensation; and director/shareholder relations issues.

Stephen Wurzburg, JDPartner, Pillsbury Winthrop Shaw Pittman LLP

Pillsbury Corporate partner Stephen Wurzburg is a trusted adviser to emerging growth and large corporations, often guiding clients through transformative, multimillion-dollar M&As and IP transactions.

Steve represents many high-tech and consumer product companies that develop, manufacture or distribute computer hardware, laser, telecommunications, chemical and solar energy products and have Software as a Service (SaaS) and App offerings. Experienced in corporation, LLC, partnership, securities, antitrust, tax, UCC and international law, he serves as outside counsel to small companies and partners with larger clients’ in-house counsel. Steve handles financing and stock liquidity matters; selling and licensing products and services; protecting and monetizing IP assets; executive and employee compensation; and director/shareholder relations issues.

closepopup
Navdeep JainSolution Architect & Lead at Thermo Fisher Scientific

Navdeep Jain is a solution architect & lead at Thermo Fisher Scientific. In his role, Mr. Jain applies advanced IT theory and methods to prove the validity of company customized concepts and to convey technical framework to the project and development team.
Mr. Jain is a specialist in automating company manual process to digital process by leveraging latest cloud technologies and various tools - Amazon web service, AWS IOT, Deep learning, Service Oriented Architecture & Advance Java.
Mr. Jain is passionate about Emerging IoT & AI technologies in healthcare and making the world a healthier and happier place.

Navdeep JainSolution Architect & Lead at Thermo Fisher Scientific

Navdeep Jain is a solution architect & lead at Thermo Fisher Scientific. In his role, Mr. Jain applies advanced IT theory and methods to prove the validity of company customized concepts and to convey technical framework to the project and development team.
Mr. Jain is a specialist in automating company manual process to digital process by leveraging latest cloud technologies and various tools - Amazon web service, AWS IOT, Deep learning, Service Oriented Architecture & Advance Java.
Mr. Jain is passionate about Emerging IoT & AI technologies in healthcare and making the world a healthier and happier place.

closepopup
Om Sharma, MSCo-founder, Data Scientist and Engineer

Om Sharma is an orange county based senior lead avionics engineer has extensive experience in AI and Data Science.

Om has two decade of hands-on software industry work experience end to end product development to start up a new company. He started working professionally before his under graduation.

He is the also lead and co-founder of Brain Wire AI. Beside that Om has been a technical blogger for many years. Om has an M.S. in Information Technology degree and B.S. in Bio-science.

Om Sharma, MSCo-founder, Data Scientist and Engineer

Om Sharma is an orange county based senior lead avionics engineer has extensive experience in AI and Data Science.

Om has two decade of hands-on software industry work experience end to end product development to start up a new company. He started working professionally before his under graduation.

He is the also lead and co-founder of Brain Wire AI. Beside that Om has been a technical blogger for many years. Om has an M.S. in Information Technology degree and B.S. in Bio-science.

closepopup
Srini Kakkera, MSChief Technology Officer, Accela

Srini Kakkera is Accela’s Chief Technology Officer, focused on overseeing critical engineering functions, technical platform strategy and management of development teams, hosting operations with embedded security and compliance. Srini is a seasoned industry veteran with an entreprenual background who has built and delivered world-class cloud products. Most recently, Srini served as SVP of Engineering and Technology at AlertEnterprise and was a member of the company’s founding team.

Previously, Srini was Vice President of Development at SAP Labs, LLC, responsible for GRC product development. In this role, he was also instrumental in establishing the co-innovation strategy with partners such as Sun Microsystems, IBM, HP, Novell and Microsoft. Prior to SAP, he held senior engineering positions at Virsa where he was dedicated to building the solution for SOX compliance which was acquired by SAP in 2016. In addition, he has held senior engineering positions at Virsa Systems acquired by SAP and Four-Soft.

Srini holds a Master’s Degree in Information and Technology and holds 10+ software patents.

Srini Kakkera, MSChief Technology Officer, Accela

Srini Kakkera is Accela’s Chief Technology Officer, focused on overseeing critical engineering functions, technical platform strategy and management of development teams, hosting operations with embedded security and compliance. Srini is a seasoned industry veteran with an entreprenual background who has built and delivered world-class cloud products. Most recently, Srini served as SVP of Engineering and Technology at AlertEnterprise and was a member of the company’s founding team.

Previously, Srini was Vice President of Development at SAP Labs, LLC, responsible for GRC product development. In this role, he was also instrumental in establishing the co-innovation strategy with partners such as Sun Microsystems, IBM, HP, Novell and Microsoft. Prior to SAP, he held senior engineering positions at Virsa where he was dedicated to building the solution for SOX compliance which was acquired by SAP in 2016. In addition, he has held senior engineering positions at Virsa Systems acquired by SAP and Four-Soft.

Srini holds a Master’s Degree in Information and Technology and holds 10+ software patents.

closepopup
Jordan WahbehManaging Partner, Bay Angels

Jordan partners with startups and investors to grow, scale, fundraise and achieve their objectives through operations, fundraising, business development, product development, and team leadership. As an experienced leader and advisor, he assists or leads in business operations and development, market growth, org transformation, and customer management. As a Partner at Andra Capital, and Bay Angels’ Managing Partner, Jordan has a strong network of resources and SMEs along with a varied portfolio of startups companies. His engagements include VCs, Angels groups, Accelerators, and Corp VC in Silicon Valley, across USA, Korea, Dubai, Brazil, MENA region, and EC.
With 20+ years’ hands-on and leadership experience, he is quite skilled in engineering, business, SW development, IT, Hi-Tech, customer management, AI, Big Data/Analytics, Industrial IoT, and manufacturing.

Jordan WahbehManaging Partner, Bay Angels

Jordan partners with startups and investors to grow, scale, fundraise and achieve their objectives through operations, fundraising, business development, product development, and team leadership. As an experienced leader and advisor, he assists or leads in business operations and development, market growth, org transformation, and customer management. As a Partner at Andra Capital, and Bay Angels’ Managing Partner, Jordan has a strong network of resources and SMEs along with a varied portfolio of startups companies. His engagements include VCs, Angels groups, Accelerators, and Corp VC in Silicon Valley, across USA, Korea, Dubai, Brazil, MENA region, and EC.
With 20+ years’ hands-on and leadership experience, he is quite skilled in engineering, business, SW development, IT, Hi-Tech, customer management, AI, Big Data/Analytics, Industrial IoT, and manufacturing.

closepopup
Chaitanya Hiremath, MS Founder, CEO, Scanta

Chaitanya, after his MSc. from Prague College, started technological research and development towards creating immersive AR/VR experiences . A dynamic, results-oriented leader with a strong track record of AR/VR and AI technologies. He pioneered and built the two of the leading augmented reality games in 2016 by utilizing keen analysis and insights and team approach to drive organizational improvements and implementation of effective practices.

He is also the first Indian origin entrepreneur to win the SharkTank Showcase and the prestigious Draper summer pitch, 2018 in San Francisco.

Chaitanya holds expertise in augmented reality, blockchain, gaming, marketing, and enterprise; building a diverse team and increasing technological adoption of augmented reality across the market. Creating use-cases for upcoming technological platforms and developing relevant strategies for their implementation. He consults companies looking to build products and innovative marketing campaigns through AR/VR that appeal to diverse audiences, track success, and deliver relevant actionable content.

Chaitanya Hiremath, MS Founder, CEO, Scanta

Chaitanya, after his MSc. from Prague College, started technological research and development towards creating immersive AR/VR experiences . A dynamic, results-oriented leader with a strong track record of AR/VR and AI technologies. He pioneered and built the two of the leading augmented reality games in 2016 by utilizing keen analysis and insights and team approach to drive organizational improvements and implementation of effective practices.

He is also the first Indian origin entrepreneur to win the SharkTank Showcase and the prestigious Draper summer pitch, 2018 in San Francisco.

Chaitanya holds expertise in augmented reality, blockchain, gaming, marketing, and enterprise; building a diverse team and increasing technological adoption of augmented reality across the market. Creating use-cases for upcoming technological platforms and developing relevant strategies for their implementation. He consults companies looking to build products and innovative marketing campaigns through AR/VR that appeal to diverse audiences, track success, and deliver relevant actionable content.

closepopup
Ajay Jotwani, MBACo-founder, CEO, i2Chain

Ajay Jotwani is the co-founder & CEO of i2Chain. He is an expert cyber-security executive with over 15 years of experience in the field. Ajay is extremely passionate in protecting the two most valuable assets – Information and Identity. Prior to i2Chain, Ajay was the global Vice President of Strategy & Product Management at IBM Global Technology Solutions Mobility business. At IBM, he incubated Digital Workplace Services (DWS) and under his leadership delivered $1B signings run rate in a year. Prior to IBM, Ajay held senior and executive leadership positions at various large technology services integrators including Wipro and Mphasis. Ajay has a MBA in Technology Management from Indian Institute of Technology, Delhi.

Ajay Jotwani, MBACo-founder, CEO, i2Chain

Ajay Jotwani is the co-founder & CEO of i2Chain. He is an expert cyber-security executive with over 15 years of experience in the field. Ajay is extremely passionate in protecting the two most valuable assets – Information and Identity. Prior to i2Chain, Ajay was the global Vice President of Strategy & Product Management at IBM Global Technology Solutions Mobility business. At IBM, he incubated Digital Workplace Services (DWS) and under his leadership delivered $1B signings run rate in a year. Prior to IBM, Ajay held senior and executive leadership positions at various large technology services integrators including Wipro and Mphasis. Ajay has a MBA in Technology Management from Indian Institute of Technology, Delhi.

closepopup
Rohan DixitFounder, Lief Therapeutics,

Rohan Dixit is founder of Lief Therapeutics, a digital health company in San Francisco. Lief's first product, an AI-driven smart patch for mental health, is used by consumers and clinicians across the country to remotely track and improve symptoms of stress, anxiety and depression.

Rohan DixitFounder, Lief Therapeutics,

Rohan Dixit is founder of Lief Therapeutics, a digital health company in San Francisco. Lief's first product, an AI-driven smart patch for mental health, is used by consumers and clinicians across the country to remotely track and improve symptoms of stress, anxiety and depression.

closepopup
Vivek Vipul, MBACo-founder/CEO Abzooba Inc.

Vivek is a Co-Founder of Abzooba Inc. and serves as its Chief Executive Officer. Mr. Vipul has 16 years of experience working for Fortune 500 companies, start-ups and "Big 4" consulting companies, which have helped him form Abzooba's vision and strategic direction. Prior to Abzooba, he served as Co-Founder and Managing Partner of BrachySolutions Inc., a healthcare technology and services company, which was acquired by Radion Global. His other relevant experience includes sales at HCL-Hewlett Packard, management consulting with PricewaterhouseCoopers Consulting (acquired by IBM), and management and operations at Tellme Networks (acquired by Microsoft). He received his B.Tech degree in engineering from Indian Institute of Technology Kanpur and his MBA from the Walter A. Haas School of Business - University of California Berkeley.

Vivek Vipul, MBACo-founder/CEO Abzooba Inc.

Vivek is a Co-Founder of Abzooba Inc. and serves as its Chief Executive Officer. Mr. Vipul has 16 years of experience working for Fortune 500 companies, start-ups and "Big 4" consulting companies, which have helped him form Abzooba's vision and strategic direction. Prior to Abzooba, he served as Co-Founder and Managing Partner of BrachySolutions Inc., a healthcare technology and services company, which was acquired by Radion Global. His other relevant experience includes sales at HCL-Hewlett Packard, management consulting with PricewaterhouseCoopers Consulting (acquired by IBM), and management and operations at Tellme Networks (acquired by Microsoft). He received his B.Tech degree in engineering from Indian Institute of Technology Kanpur and his MBA from the Walter A. Haas School of Business - University of California Berkeley.

closepopup
Diane Ding Laren, MBAManaging Partner at Ding Ventures

Diane Ding Laren is the founder at Ding Ventures, which is a seed venture fund that focusing on automation and AI related hardware. Previously she works as a partner of Shenzhen Valley Ventures, an accelerator that focusing on helping hardware startup with the design for manufacturing phase. Before that she had held the position as head of admission and China partner for Founder Institute, world biggest startup accelerator and entrepreneur training program. She Co-founded Angelhere, a seed stage incubator and angel fund in multiple cities in China, her portfolio including: Arraiy,Metalpay, Catalia Health, Naked Lab,Lily App, Drop, CALA

Diane Ding Laren, MBAManaging Partner at Ding Ventures

Diane Ding Laren is the founder at Ding Ventures, which is a seed venture fund that focusing on automation and AI related hardware. Previously she works as a partner of Shenzhen Valley Ventures, an accelerator that focusing on helping hardware startup with the design for manufacturing phase. Before that she had held the position as head of admission and China partner for Founder Institute, world biggest startup accelerator and entrepreneur training program. She Co-founded Angelhere, a seed stage incubator and angel fund in multiple cities in China, her portfolio including: Arraiy,Metalpay, Catalia Health, Naked Lab,Lily App, Drop, CALA

closepopup
Ela Heussen, PhD, MBADirector, Abreos Biosciences

Ela Heussen leads Corporate Strategy for the precision medicine startup Abreos Bioscience. She completed her PhD in Biomathematical Modeling at University College London, before moving into technology transfer and rounding off her education at London Business School and completing an MBA at Stanford. While at Stanford, Dr Heussen became a founding member of Stanford GSB Impact Fund and led the on campus accelerator Cardinal Ventures. Dr Heussen is passionate about the intersection of data and biosciences, and the immense potential this quickly growing fields has for patient outcomes.

Ela Heussen, PhD, MBADirector, Abreos Biosciences

Ela Heussen leads Corporate Strategy for the precision medicine startup Abreos Bioscience. She completed her PhD in Biomathematical Modeling at University College London, before moving into technology transfer and rounding off her education at London Business School and completing an MBA at Stanford. While at Stanford, Dr Heussen became a founding member of Stanford GSB Impact Fund and led the on campus accelerator Cardinal Ventures. Dr Heussen is passionate about the intersection of data and biosciences, and the immense potential this quickly growing fields has for patient outcomes.

closepopup
Swati Chaturvedi, MBACo-founder and CEO at Propel(x)

Swati is the co-founder and CEO of Propel(x) - an investment platform that enables investments in deep technology startups. Prior to starting Propel(x), Swati was an investment professional at Exigen Capital, where she worked on IT Telecom, Travel, and BPO deals. Before that, she was a management consultant working across a variety of industries. Swati is the co-founder of the MIT Alumni Angel Investors group. She founded and led the group 2013 – 2015, and continues to be on the screening committee. Swati has an MBA from the MIT Sloan School of Management, an M.S. from MIT, an M.S. from UC Berkeley, and a Bachelor’s degree from the Indian Institute of Technology, Roorkee. Outside of work, Swati loves to spend time with family, watch movies and read.

Swati Chaturvedi, MBACo-founder and CEO at Propel(x)

Swati is the co-founder and CEO of Propel(x) - an investment platform that enables investments in deep technology startups. Prior to starting Propel(x), Swati was an investment professional at Exigen Capital, where she worked on IT Telecom, Travel, and BPO deals. Before that, she was a management consultant working across a variety of industries. Swati is the co-founder of the MIT Alumni Angel Investors group. She founded and led the group 2013 – 2015, and continues to be on the screening committee. Swati has an MBA from the MIT Sloan School of Management, an M.S. from MIT, an M.S. from UC Berkeley, and a Bachelor’s degree from the Indian Institute of Technology, Roorkee. Outside of work, Swati loves to spend time with family, watch movies and read.

closepopup
Miten MehtaAngel Investor, Consultant Google

Miten is client facing strategic Technology leader equipped with powerful communication, coordination and analytic skills, along with a proven track record of exceptional leadership ability.

He is deeply passionate about leveraging advance technologies like Cloud, BigData, AI / ML, IOT, RPA and Blockchain to solve complex customer and user problems, streamline and automate processes, organize information and data, build and scale efficient and transparent value chain, ecosystem and markets, create and grow new business models & revenue channels and deliver sustainable business ROI and social impact.

He strives to achieve the same through continuously challenging, learning, adapting and evolving in a rapidly changing business environment.

Miten brings over 20 years of technology experience in product / program / project management, strategic alliance, business development, partnerships, go2market campaigns across US, Europe and Asia for F2000 companies like Google, Qualcomm & infoSpace to two startups where he was a part of co-founding team.

He is proficient in building & growing solutions offering (practice), working with strategic partners around - Cloud (GCP and AWS), ML (TF and Watson), RPA (Automation Anywhere and Uipath), IOT (GE and C3IOT) and Blockchain (DigitalAsset and BlockApps), Enteprise Knowledge Management (Edcast) Mobility, Analytics among others.

He has hands-on experience in leading and rolling out global developer and co-innovation programs with ecosystem, and proven expertise in building, nurturing and growing vibrant, user, developer and partner communities and engaging the ecosystem in MVP / POC of product and in beta / pilot release to improve and enhance UX and drive adoption.

Miten MehtaAngel Investor, Consultant Google

Miten is client facing strategic Technology leader equipped with powerful communication, coordination and analytic skills, along with a proven track record of exceptional leadership ability.

He is deeply passionate about leveraging advance technologies like Cloud, BigData, AI / ML, IOT, RPA and Blockchain to solve complex customer and user problems, streamline and automate processes, organize information and data, build and scale efficient and transparent value chain, ecosystem and markets, create and grow new business models & revenue channels and deliver sustainable business ROI and social impact.

He strives to achieve the same through continuously challenging, learning, adapting and evolving in a rapidly changing business environment.

Miten brings over 20 years of technology experience in product / program / project management, strategic alliance, business development, partnerships, go2market campaigns across US, Europe and Asia for F2000 companies like Google, Qualcomm & infoSpace to two startups where he was a part of co-founding team.

He is proficient in building & growing solutions offering (practice), working with strategic partners around - Cloud (GCP and AWS), ML (TF and Watson), RPA (Automation Anywhere and Uipath), IOT (GE and C3IOT) and Blockchain (DigitalAsset and BlockApps), Enteprise Knowledge Management (Edcast) Mobility, Analytics among others.

He has hands-on experience in leading and rolling out global developer and co-innovation programs with ecosystem, and proven expertise in building, nurturing and growing vibrant, user, developer and partner communities and engaging the ecosystem in MVP / POC of product and in beta / pilot release to improve and enhance UX and drive adoption.

closepopup
Mark Froimson MD, MBAPrincipal, Riverside Health Advisors

Surgeon/Executive, with proven success in building and leading teams, improving clinical and business practices, driving innovation, delivering value, enhancing quality and safety, optimizing patient experience, redesigning care, and achieving success in bundled payment and other new healthcare delivery models.

Mark Froimson MD, MBAPrincipal, Riverside Health Advisors

Surgeon/Executive, with proven success in building and leading teams, improving clinical and business practices, driving innovation, delivering value, enhancing quality and safety, optimizing patient experience, redesigning care, and achieving success in bundled payment and other new healthcare delivery models.

closepopup
Henry Wong, MBAMD-Diamond Tech Ventures & Garage Capital III

Henry H. Wong has been a prolific and successful entrepreneur, executive mentor and venture investor in Silicon Valley for dozen of years. Henry applies his operational experience, investment talent, and his international expertise to advise, invest in, and build high technology companies with a global vision.

To cope with the fast growing high tech industry, Henry mentors companies and executives to be prepared and plan ahead to deal with the ever-changing dynamic future.

Currently he is the Managing Director in Garage Capital Fund #3, and also the founder of Diamond TechVentures (a family office). Prior to that, Henry was a venture partner at Crystal Ventures where he was actively involved with companies including SMIC, LGC Wireless & Infinera. As an entrepreneur, Henry has had several significant successes, including SS8 Networks Inc., where he was the founder, CEO and Chairman, as well as IP Communications, XaQti Semiconductor, CNet Technology Inc., and Combinet (ISDN Systems), all of which he co-founded, funded and led.

In 2002, Henry was a finalist for the Ernst & Young “Entrepreneur of the Year Award.” Henry is the chairman of CSPA.com, a 501(c)3 non-profit. He volunteers as an advisor to several non-profit organizations & is active in the community. Henry holds a BSc degree in Business from the University of Utah & a MBA in Telecom Management from Golden Gate University. He is also a Mentor in the Stanford Graduate School of Business GSB MBA Program, and a Team Mentor in the Technology Venture Formation course MS&E 273 & E145 at Stanford's School of Engineering.

Henry Wong, MBAMD-Diamond Tech Ventures & Garage Capital III

Henry H. Wong has been a prolific and successful entrepreneur, executive mentor and venture investor in Silicon Valley for dozen of years. Henry applies his operational experience, investment talent, and his international expertise to advise, invest in, and build high technology companies with a global vision.

To cope with the fast growing high tech industry, Henry mentors companies and executives to be prepared and plan ahead to deal with the ever-changing dynamic future.

Currently he is the Managing Director in Garage Capital Fund #3, and also the founder of Diamond TechVentures (a family office). Prior to that, Henry was a venture partner at Crystal Ventures where he was actively involved with companies including SMIC, LGC Wireless & Infinera. As an entrepreneur, Henry has had several significant successes, including SS8 Networks Inc., where he was the founder, CEO and Chairman, as well as IP Communications, XaQti Semiconductor, CNet Technology Inc., and Combinet (ISDN Systems), all of which he co-founded, funded and led.

In 2002, Henry was a finalist for the Ernst & Young “Entrepreneur of the Year Award.” Henry is the chairman of CSPA.com, a 501(c)3 non-profit. He volunteers as an advisor to several non-profit organizations & is active in the community. Henry holds a BSc degree in Business from the University of Utah & a MBA in Telecom Management from Golden Gate University. He is also a Mentor in the Stanford Graduate School of Business GSB MBA Program, and a Team Mentor in the Technology Venture Formation course MS&E 273 & E145 at Stanford's School of Engineering.

closepopup
Nilesh Trivedi, MBAFund Advisor, Altius Ventures

Over two decades of Operational, Technology Management and creating new businesses experience at fortune corporations and early stage companies. I have helped create and guide more than a dozen new companies from ground up. Many of them venture capital backed, in sectors ranging from Enterprise Software, Security, Mobile Tech, B2B, Hardware and Frontier Technologies such as Aeriel Vehicles, 3D Printing, Connected Cars and Autonomous Vehicles.

In my corporate life, I have held numerous positions ranging from managing operations and programs ranging from $100M+ development cost that eventually went on to create $1Bln run rate product lines and category defining products winning >70% market share in Service Provider and Enterprise market segments. At corporations, I have been responsible to incubate innovation and help build and launch new businesses and product lines at Advance Technology Groups, such as in Content Delivery Networks, IPv6 Technology, Carrier Grade NAT and Security & Connected Vehicles (yes, dating as far back to 2001 with Ford and Microsoft). Early on in my career, I designed and developed products ranging from VoIP, Security, Video, Data Communications infrastructure, Data Center Technologies and Telecom Networks.

Nilesh Trivedi, MBAFund Advisor, Altius Ventures

Over two decades of Operational, Technology Management and creating new businesses experience at fortune corporations and early stage companies. I have helped create and guide more than a dozen new companies from ground up. Many of them venture capital backed, in sectors ranging from Enterprise Software, Security, Mobile Tech, B2B, Hardware and Frontier Technologies such as Aeriel Vehicles, 3D Printing, Connected Cars and Autonomous Vehicles.

In my corporate life, I have held numerous positions ranging from managing operations and programs ranging from $100M+ development cost that eventually went on to create $1Bln run rate product lines and category defining products winning >70% market share in Service Provider and Enterprise market segments. At corporations, I have been responsible to incubate innovation and help build and launch new businesses and product lines at Advance Technology Groups, such as in Content Delivery Networks, IPv6 Technology, Carrier Grade NAT and Security & Connected Vehicles (yes, dating as far back to 2001 with Ford and Microsoft). Early on in my career, I designed and developed products ranging from VoIP, Security, Video, Data Communications infrastructure, Data Center Technologies and Telecom Networks.

closepopup
Suraj Kumar RajwaniManaging Partner, DoubleRock

Suraj Kumar Rajwani is a co-founder and partner of DoubleRock. He has lived in Beijing and Shanghai for over 3 years and is always pushing for his portfolio companies to expand internationally.

He has over seven years of management, mergers and acquisitions experience in Silicon Valley, China and India.

He was the Managing Director of the Global Network Entrepreneurs Network Organization (GENO), an entrepreneur organization with over 27 chapters worldwide. As head of sales and marketing, he grew GENO's footprint to over 23 countries and led product expansion into new areas such as enterprise pricing and enterprise incentive management.

He has advised on mergers and acquisitions in multiple industries including IT, financial services, real estate, and construction. During his tenure at GENO, he developed the GENO Venture Connect framework which served as a platform for entrepreneurs to meet with potential investors which led to the birth and expansion of many successful enterprises.

He has also been invited as a speaker to many conferences including the World HRD (Human Resource & Development Congress) and the World Entrepreneur Summit by Ernst & Young sharing his views on entrepreneurial leadership in Bahrain and Monte Carlo. He has also coached and advised entrepreneurs through his involvement with the Kauffman Foundation.

Suraj Kumar RajwaniManaging Partner, DoubleRock

Suraj Kumar Rajwani is a co-founder and partner of DoubleRock. He has lived in Beijing and Shanghai for over 3 years and is always pushing for his portfolio companies to expand internationally.

He has over seven years of management, mergers and acquisitions experience in Silicon Valley, China and India.

He was the Managing Director of the Global Network Entrepreneurs Network Organization (GENO), an entrepreneur organization with over 27 chapters worldwide. As head of sales and marketing, he grew GENO's footprint to over 23 countries and led product expansion into new areas such as enterprise pricing and enterprise incentive management.

He has advised on mergers and acquisitions in multiple industries including IT, financial services, real estate, and construction. During his tenure at GENO, he developed the GENO Venture Connect framework which served as a platform for entrepreneurs to meet with potential investors which led to the birth and expansion of many successful enterprises.

He has also been invited as a speaker to many conferences including the World HRD (Human Resource & Development Congress) and the World Entrepreneur Summit by Ernst & Young sharing his views on entrepreneurial leadership in Bahrain and Monte Carlo. He has also coached and advised entrepreneurs through his involvement with the Kauffman Foundation.

closepopup

Testimonials

See what other people are saying about us

PRASUN MISHRA, MS, PhD
PRASUN MISHRA, MS, PhDAGILITY PHARMA

"On February 6th-8th, AAPM & Google will host DataAI National Summit (#DANS2019). And you'll see why 2019 won't be like '2019."

RITA HUMENIUK, MS, MEng. PhD
RITA HUMENIUK, MS, MEng. PhDGILEAD SCIENCES

“With the theme to augment healthcare with technology, DANS is an attempting to bridge the gap between Tech, Medtech and Pharma worlds by bringing movers and shakers in the field together. I am so looking forward to it.”

Hurry Up and Get Your Tickets Before they are Sold Out!

Look forward to welcoming you at DANS!

Sponsorship Opportunities

DANS attracts executives, investors, entrepreneurs, high-profile speakers & participants from companies/institutions throughout the world. The organizers of this important initiative greatly acknowledge and salute your organisation’s support & contributions in promoting DANS2019. For sponsorship opportunities please get in touch with sheila@dans.ai

Contact us

Become a part of DANS community

Get in touch with us

We look forward to hearing from you!